CN105687788A - Pharmaceutical composition capable of softening blood vessels and application thereof - Google Patents
Pharmaceutical composition capable of softening blood vessels and application thereof Download PDFInfo
- Publication number
- CN105687788A CN105687788A CN201610125271.9A CN201610125271A CN105687788A CN 105687788 A CN105687788 A CN 105687788A CN 201610125271 A CN201610125271 A CN 201610125271A CN 105687788 A CN105687788 A CN 105687788A
- Authority
- CN
- China
- Prior art keywords
- parts
- radix
- rhizoma
- pharmaceutical composition
- grams
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000008194 pharmaceutical composition Substances 0.000 title claims abstract description 47
- 210000004204 blood vessel Anatomy 0.000 title abstract description 13
- 239000003814 drug Substances 0.000 claims abstract description 56
- 241000180649 Panax notoginseng Species 0.000 claims abstract description 30
- 235000003143 Panax notoginseng Nutrition 0.000 claims abstract description 30
- 210000000582 semen Anatomy 0.000 claims abstract description 30
- 241000628997 Flos Species 0.000 claims abstract description 29
- 241000283956 Manis Species 0.000 claims abstract description 25
- 235000011201 Ginkgo Nutrition 0.000 claims abstract description 24
- 235000008100 Ginkgo biloba Nutrition 0.000 claims abstract description 24
- 239000002994 raw material Substances 0.000 claims abstract description 17
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 39
- 241001619461 Poria <basidiomycete fungus> Species 0.000 claims description 28
- 235000017159 Crataegus pinnatifida Nutrition 0.000 claims description 26
- 241000657480 Crataegus pinnatifida Species 0.000 claims description 26
- 241000522620 Scorpio Species 0.000 claims description 26
- 239000009490 scorpio Substances 0.000 claims description 26
- 241000237636 Pheretima Species 0.000 claims description 24
- 241000218628 Ginkgo Species 0.000 claims description 23
- 239000000203 mixture Substances 0.000 claims description 22
- 239000008187 granular material Substances 0.000 claims description 21
- 239000000284 extract Substances 0.000 claims description 17
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 15
- 239000000706 filtrate Substances 0.000 claims description 12
- 238000002156 mixing Methods 0.000 claims description 12
- 239000007788 liquid Substances 0.000 claims description 10
- 229930006000 Sucrose Natural products 0.000 claims description 9
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 claims description 9
- 229940079593 drug Drugs 0.000 claims description 9
- -1 dry Substances 0.000 claims description 9
- 238000000605 extraction Methods 0.000 claims description 9
- 238000010438 heat treatment Methods 0.000 claims description 9
- 239000005720 sucrose Substances 0.000 claims description 9
- 239000000080 wetting agent Substances 0.000 claims description 9
- 239000004375 Dextrin Substances 0.000 claims description 6
- 229920001353 Dextrin Polymers 0.000 claims description 6
- 239000003795 chemical substances by application Substances 0.000 claims description 6
- 235000019425 dextrin Nutrition 0.000 claims description 6
- 238000001914 filtration Methods 0.000 claims description 6
- 238000000108 ultra-filtration Methods 0.000 claims description 6
- 230000002829 reductive effect Effects 0.000 claims description 4
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 claims description 3
- WQZGKKKJIJFFOK-PHYPRBDBSA-N alpha-D-galactose Chemical compound OC[C@H]1O[C@H](O)[C@H](O)[C@@H](O)[C@H]1O WQZGKKKJIJFFOK-PHYPRBDBSA-N 0.000 claims description 3
- 239000002775 capsule Substances 0.000 claims description 3
- 230000006837 decompression Effects 0.000 claims description 3
- 238000002481 ethanol extraction Methods 0.000 claims description 3
- 239000012567 medical material Substances 0.000 claims description 3
- 235000011837 pasties Nutrition 0.000 claims description 3
- 239000000843 powder Substances 0.000 claims description 3
- 238000004064 recycling Methods 0.000 claims description 3
- 239000000741 silica gel Substances 0.000 claims description 3
- 229910002027 silica gel Inorganic materials 0.000 claims description 3
- 238000001694 spray drying Methods 0.000 claims description 3
- 230000001954 sterilising effect Effects 0.000 claims description 3
- 238000003756 stirring Methods 0.000 claims description 3
- 239000006228 supernatant Substances 0.000 claims description 3
- 210000004369 blood Anatomy 0.000 abstract description 78
- 239000008280 blood Substances 0.000 abstract description 78
- 230000000694 effects Effects 0.000 abstract description 40
- 230000006870 function Effects 0.000 abstract description 16
- 206010020772 Hypertension Diseases 0.000 abstract description 15
- 230000017531 blood circulation Effects 0.000 abstract description 14
- 230000001105 regulatory effect Effects 0.000 abstract description 7
- 238000005516 engineering process Methods 0.000 abstract description 4
- 241000721047 Danaus plexippus Species 0.000 abstract description 3
- 238000002360 preparation method Methods 0.000 abstract description 3
- 210000001835 viscera Anatomy 0.000 abstract description 3
- 240000000249 Morus alba Species 0.000 abstract description 2
- 235000008708 Morus alba Nutrition 0.000 abstract description 2
- 231100000331 toxic Toxicity 0.000 abstract description 2
- 230000002588 toxic effect Effects 0.000 abstract description 2
- 235000009051 Ambrosia paniculata var. peruviana Nutrition 0.000 abstract 1
- 241000382455 Angelica sinensis Species 0.000 abstract 1
- 235000003097 Artemisia absinthium Nutrition 0.000 abstract 1
- 240000001851 Artemisia dracunculus Species 0.000 abstract 1
- 235000017731 Artemisia dracunculus ssp. dracunculus Nutrition 0.000 abstract 1
- 235000003261 Artemisia vulgaris Nutrition 0.000 abstract 1
- 244000037364 Cinnamomum aromaticum Species 0.000 abstract 1
- 235000014489 Cinnamomum aromaticum Nutrition 0.000 abstract 1
- 235000014283 Crataegus pinnatifida var major Nutrition 0.000 abstract 1
- 241000123854 Crataegus pinnatifida var. major Species 0.000 abstract 1
- 244000194101 Ginkgo biloba Species 0.000 abstract 1
- 241000243684 Lumbricus Species 0.000 abstract 1
- 240000002853 Nelumbo nucifera Species 0.000 abstract 1
- 235000006508 Nelumbo nucifera Nutrition 0.000 abstract 1
- 235000006510 Nelumbo pentapetala Nutrition 0.000 abstract 1
- 244000197580 Poria cocos Species 0.000 abstract 1
- 235000008599 Poria cocos Nutrition 0.000 abstract 1
- 244000046146 Pueraria lobata Species 0.000 abstract 1
- 235000010575 Pueraria lobata Nutrition 0.000 abstract 1
- 241000304195 Salvia miltiorrhiza Species 0.000 abstract 1
- 235000011135 Salvia miltiorrhiza Nutrition 0.000 abstract 1
- 241000239226 Scorpiones Species 0.000 abstract 1
- 241001521901 Tribulus lanuginosus Species 0.000 abstract 1
- 239000001138 artemisia absinthium Substances 0.000 abstract 1
- KDYFGRWQOYBRFD-UHFFFAOYSA-N succinic acid Chemical compound OC(=O)CCC(O)=O KDYFGRWQOYBRFD-UHFFFAOYSA-N 0.000 abstract 1
- 208000002193 Pain Diseases 0.000 description 28
- 210000004185 liver Anatomy 0.000 description 25
- 230000036407 pain Effects 0.000 description 25
- 208000031226 Hyperlipidaemia Diseases 0.000 description 22
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 21
- 210000000952 spleen Anatomy 0.000 description 21
- 238000011282 treatment Methods 0.000 description 17
- 201000010099 disease Diseases 0.000 description 16
- 230000001737 promoting effect Effects 0.000 description 15
- 230000036772 blood pressure Effects 0.000 description 13
- 210000002216 heart Anatomy 0.000 description 13
- 208000006820 Arthralgia Diseases 0.000 description 12
- 210000001015 abdomen Anatomy 0.000 description 12
- 235000009508 confectionery Nutrition 0.000 description 12
- 206010012601 diabetes mellitus Diseases 0.000 description 12
- 201000000736 Amenorrhea Diseases 0.000 description 11
- 206010001928 Amenorrhoea Diseases 0.000 description 11
- 231100000540 amenorrhea Toxicity 0.000 description 11
- 206010012735 Diarrhoea Diseases 0.000 description 10
- 206010019233 Headaches Diseases 0.000 description 10
- 206010062717 Increased upper airway secretion Diseases 0.000 description 10
- 206010030113 Oedema Diseases 0.000 description 10
- 231100000869 headache Toxicity 0.000 description 10
- 208000026435 phlegm Diseases 0.000 description 10
- 208000004880 Polyuria Diseases 0.000 description 9
- 230000035619 diuresis Effects 0.000 description 9
- 208000002173 dizziness Diseases 0.000 description 9
- 210000003734 kidney Anatomy 0.000 description 9
- 210000004072 lung Anatomy 0.000 description 9
- 210000003205 muscle Anatomy 0.000 description 9
- 230000001717 pathogenic effect Effects 0.000 description 9
- 206010011224 Cough Diseases 0.000 description 8
- 239000007789 gas Substances 0.000 description 8
- 238000000034 method Methods 0.000 description 8
- 239000000243 solution Substances 0.000 description 8
- 210000002784 stomach Anatomy 0.000 description 8
- 206010013935 Dysmenorrhoea Diseases 0.000 description 7
- 206010023126 Jaundice Diseases 0.000 description 7
- 230000007812 deficiency Effects 0.000 description 7
- 238000001990 intravenous administration Methods 0.000 description 7
- 208000024172 Cardiovascular disease Diseases 0.000 description 6
- 206010010904 Convulsion Diseases 0.000 description 6
- 208000005171 Dysmenorrhea Diseases 0.000 description 6
- 241000699670 Mus sp. Species 0.000 description 6
- 208000025747 Rheumatic disease Diseases 0.000 description 6
- 208000006673 asthma Diseases 0.000 description 6
- 230000036461 convulsion Effects 0.000 description 6
- 241000411851 herbal medicine Species 0.000 description 6
- 208000014674 injury Diseases 0.000 description 6
- 230000000552 rheumatic effect Effects 0.000 description 6
- 230000008961 swelling Effects 0.000 description 6
- 206010002383 Angina Pectoris Diseases 0.000 description 5
- 206010007247 Carbuncle Diseases 0.000 description 5
- 208000019255 Menstrual disease Diseases 0.000 description 5
- 208000027418 Wounds and injury Diseases 0.000 description 5
- 208000026106 cerebrovascular disease Diseases 0.000 description 5
- 230000034994 death Effects 0.000 description 5
- 201000005577 familial hyperlipidemia Diseases 0.000 description 5
- 235000013305 food Nutrition 0.000 description 5
- 210000000232 gallbladder Anatomy 0.000 description 5
- 230000001077 hypotensive effect Effects 0.000 description 5
- 239000000463 material Substances 0.000 description 5
- 244000052769 pathogen Species 0.000 description 5
- 231100000614 poison Toxicity 0.000 description 5
- 235000019640 taste Nutrition 0.000 description 5
- 238000012360 testing method Methods 0.000 description 5
- UFTFJSFQGQCHQW-UHFFFAOYSA-N triformin Chemical compound O=COCC(OC=O)COC=O UFTFJSFQGQCHQW-UHFFFAOYSA-N 0.000 description 5
- 206010003210 Arteriosclerosis Diseases 0.000 description 4
- 206010008190 Cerebrovascular accident Diseases 0.000 description 4
- 241001465754 Metazoa Species 0.000 description 4
- 206010028980 Neoplasm Diseases 0.000 description 4
- 208000006011 Stroke Diseases 0.000 description 4
- 206010047700 Vomiting Diseases 0.000 description 4
- 230000009471 action Effects 0.000 description 4
- 230000000259 anti-tumor effect Effects 0.000 description 4
- 208000011775 arteriosclerosis disease Diseases 0.000 description 4
- 230000008901 benefit Effects 0.000 description 4
- 210000000988 bone and bone Anatomy 0.000 description 4
- 238000007705 chemical test Methods 0.000 description 4
- 210000000038 chest Anatomy 0.000 description 4
- LQGUBLBATBMXHT-UHFFFAOYSA-N chrysophanol Chemical compound C1=CC=C2C(=O)C3=CC(C)=CC(O)=C3C(=O)C2=C1O LQGUBLBATBMXHT-UHFFFAOYSA-N 0.000 description 4
- 208000029078 coronary artery disease Diseases 0.000 description 4
- 230000006378 damage Effects 0.000 description 4
- 235000005911 diet Nutrition 0.000 description 4
- 230000037213 diet Effects 0.000 description 4
- 208000035475 disorder Diseases 0.000 description 4
- 230000002526 effect on cardiovascular system Effects 0.000 description 4
- 230000001939 inductive effect Effects 0.000 description 4
- 230000033001 locomotion Effects 0.000 description 4
- 230000002175 menstrual effect Effects 0.000 description 4
- 230000000144 pharmacologic effect Effects 0.000 description 4
- 238000005728 strengthening Methods 0.000 description 4
- 208000011580 syndromic disease Diseases 0.000 description 4
- 230000008673 vomiting Effects 0.000 description 4
- 206010000077 Abdominal mass Diseases 0.000 description 3
- 206010010774 Constipation Diseases 0.000 description 3
- 206010062575 Muscle contracture Diseases 0.000 description 3
- 241000283973 Oryctolagus cuniculus Species 0.000 description 3
- 206010033799 Paralysis Diseases 0.000 description 3
- 230000002159 abnormal effect Effects 0.000 description 3
- 238000009825 accumulation Methods 0.000 description 3
- 230000003213 activating effect Effects 0.000 description 3
- 230000003110 anti-inflammatory effect Effects 0.000 description 3
- 230000036528 appetite Effects 0.000 description 3
- 235000019789 appetite Nutrition 0.000 description 3
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 3
- 210000004556 brain Anatomy 0.000 description 3
- 230000008859 change Effects 0.000 description 3
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 3
- 230000004087 circulation Effects 0.000 description 3
- 208000006111 contracture Diseases 0.000 description 3
- 230000001276 controlling effect Effects 0.000 description 3
- 230000003247 decreasing effect Effects 0.000 description 3
- 239000002934 diuretic Substances 0.000 description 3
- 230000001882 diuretic effect Effects 0.000 description 3
- 208000001848 dysentery Diseases 0.000 description 3
- 201000006549 dyspepsia Diseases 0.000 description 3
- 206010013990 dysuria Diseases 0.000 description 3
- 230000002708 enhancing effect Effects 0.000 description 3
- 206010015037 epilepsy Diseases 0.000 description 3
- 210000001624 hip Anatomy 0.000 description 3
- 230000001965 increasing effect Effects 0.000 description 3
- 230000000302 ischemic effect Effects 0.000 description 3
- 230000014759 maintenance of location Effects 0.000 description 3
- 230000002107 myocardial effect Effects 0.000 description 3
- 210000004165 myocardium Anatomy 0.000 description 3
- 210000000056 organ Anatomy 0.000 description 3
- 239000001301 oxygen Substances 0.000 description 3
- 229910052760 oxygen Inorganic materials 0.000 description 3
- 239000000047 product Substances 0.000 description 3
- 206010040872 skin infection Diseases 0.000 description 3
- 208000024891 symptom Diseases 0.000 description 3
- 206010042772 syncope Diseases 0.000 description 3
- 230000001225 therapeutic effect Effects 0.000 description 3
- 238000002560 therapeutic procedure Methods 0.000 description 3
- 239000003440 toxic substance Substances 0.000 description 3
- SFLSHLFXELFNJZ-QMMMGPOBSA-N (-)-norepinephrine Chemical compound NC[C@H](O)C1=CC=C(O)C(O)=C1 SFLSHLFXELFNJZ-QMMMGPOBSA-N 0.000 description 2
- 208000004998 Abdominal Pain Diseases 0.000 description 2
- 201000001320 Atherosclerosis Diseases 0.000 description 2
- 206010009346 Clonus Diseases 0.000 description 2
- 206010051625 Conjunctival hyperaemia Diseases 0.000 description 2
- 102100030797 Conserved oligomeric Golgi complex subunit 2 Human genes 0.000 description 2
- 208000034656 Contusions Diseases 0.000 description 2
- 206010013954 Dysphoria Diseases 0.000 description 2
- 208000000059 Dyspnea Diseases 0.000 description 2
- 206010013975 Dyspnoeas Diseases 0.000 description 2
- 241000282326 Felis catus Species 0.000 description 2
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 2
- 102000015779 HDL Lipoproteins Human genes 0.000 description 2
- 108010010234 HDL Lipoproteins Proteins 0.000 description 2
- 101000920113 Homo sapiens Conserved oligomeric Golgi complex subunit 2 Proteins 0.000 description 2
- 208000008454 Hyperhidrosis Diseases 0.000 description 2
- 206010021118 Hypotonia Diseases 0.000 description 2
- 206010021143 Hypoxia Diseases 0.000 description 2
- 206010061216 Infarction Diseases 0.000 description 2
- 206010033557 Palpitations Diseases 0.000 description 2
- 235000003140 Panax quinquefolius Nutrition 0.000 description 2
- 208000003251 Pruritus Diseases 0.000 description 2
- 208000001431 Psychomotor Agitation Diseases 0.000 description 2
- 206010038743 Restlessness Diseases 0.000 description 2
- 208000034189 Sclerosis Diseases 0.000 description 2
- 208000005392 Spasm Diseases 0.000 description 2
- 208000007536 Thrombosis Diseases 0.000 description 2
- 208000037386 Typhoid Diseases 0.000 description 2
- 208000025865 Ulcer Diseases 0.000 description 2
- 241000700605 Viruses Species 0.000 description 2
- 206010052428 Wound Diseases 0.000 description 2
- 208000019790 abdominal distention Diseases 0.000 description 2
- 230000005856 abnormality Effects 0.000 description 2
- 230000002776 aggregation Effects 0.000 description 2
- 230000000202 analgesic effect Effects 0.000 description 2
- 230000000844 anti-bacterial effect Effects 0.000 description 2
- 230000001754 anti-pyretic effect Effects 0.000 description 2
- 239000003146 anticoagulant agent Substances 0.000 description 2
- 239000002221 antipyretic Substances 0.000 description 2
- 230000006793 arrhythmia Effects 0.000 description 2
- 206010003119 arrhythmia Diseases 0.000 description 2
- 206010003549 asthenia Diseases 0.000 description 2
- 230000003542 behavioural effect Effects 0.000 description 2
- 235000019658 bitter taste Nutrition 0.000 description 2
- 230000037396 body weight Effects 0.000 description 2
- 208000034526 bruise Diseases 0.000 description 2
- 230000001914 calming effect Effects 0.000 description 2
- 150000001720 carbohydrates Chemical class 0.000 description 2
- 210000000748 cardiovascular system Anatomy 0.000 description 2
- 210000004351 coronary vessel Anatomy 0.000 description 2
- 230000002950 deficient Effects 0.000 description 2
- 238000011161 development Methods 0.000 description 2
- 230000018109 developmental process Effects 0.000 description 2
- 230000003203 everyday effect Effects 0.000 description 2
- 201000005884 exanthem Diseases 0.000 description 2
- 208000016253 exhaustion Diseases 0.000 description 2
- 239000003172 expectorant agent Substances 0.000 description 2
- 230000003419 expectorant effect Effects 0.000 description 2
- 230000004438 eyesight Effects 0.000 description 2
- 208000017561 flaccidity Diseases 0.000 description 2
- 229930003935 flavonoid Natural products 0.000 description 2
- 150000002215 flavonoids Chemical class 0.000 description 2
- 235000017173 flavonoids Nutrition 0.000 description 2
- 239000008103 glucose Substances 0.000 description 2
- 230000036541 health Effects 0.000 description 2
- 230000023597 hemostasis Effects 0.000 description 2
- 208000021760 high fever Diseases 0.000 description 2
- 201000001421 hyperglycemia Diseases 0.000 description 2
- 230000036039 immunity Effects 0.000 description 2
- 230000007574 infarction Effects 0.000 description 2
- 239000004615 ingredient Substances 0.000 description 2
- NOESYZHRGYRDHS-UHFFFAOYSA-N insulin Chemical compound N1C(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(NC(=O)CN)C(C)CC)CSSCC(C(NC(CO)C(=O)NC(CC(C)C)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CCC(N)=O)C(=O)NC(CC(C)C)C(=O)NC(CCC(O)=O)C(=O)NC(CC(N)=O)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CSSCC(NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2C=CC(O)=CC=2)NC(=O)C(CC(C)C)NC(=O)C(C)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2NC=NC=2)NC(=O)C(CO)NC(=O)CNC2=O)C(=O)NCC(=O)NC(CCC(O)=O)C(=O)NC(CCCNC(N)=N)C(=O)NCC(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC(O)=CC=3)C(=O)NC(C(C)O)C(=O)N3C(CCC3)C(=O)NC(CCCCN)C(=O)NC(C)C(O)=O)C(=O)NC(CC(N)=O)C(O)=O)=O)NC(=O)C(C(C)CC)NC(=O)C(CO)NC(=O)C(C(C)O)NC(=O)C1CSSCC2NC(=O)C(CC(C)C)NC(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CC(N)=O)NC(=O)C(NC(=O)C(N)CC=1C=CC=CC=1)C(C)C)CC1=CN=CN1 NOESYZHRGYRDHS-UHFFFAOYSA-N 0.000 description 2
- 210000000629 knee joint Anatomy 0.000 description 2
- 201000007227 lymph node tuberculosis Diseases 0.000 description 2
- 206010025482 malaise Diseases 0.000 description 2
- 230000003211 malignant effect Effects 0.000 description 2
- 239000002398 materia medica Substances 0.000 description 2
- 230000005906 menstruation Effects 0.000 description 2
- 230000004089 microcirculation Effects 0.000 description 2
- 231100000957 no side effect Toxicity 0.000 description 2
- 229960002748 norepinephrine Drugs 0.000 description 2
- SFLSHLFXELFNJZ-UHFFFAOYSA-N norepinephrine Natural products NCC(O)C1=CC=C(O)C(O)=C1 SFLSHLFXELFNJZ-UHFFFAOYSA-N 0.000 description 2
- 231100000862 numbness Toxicity 0.000 description 2
- 230000036284 oxygen consumption Effects 0.000 description 2
- 239000002574 poison Substances 0.000 description 2
- 230000008569 process Effects 0.000 description 2
- 230000001047 pyretic effect Effects 0.000 description 2
- 206010037844 rash Diseases 0.000 description 2
- 238000011160 research Methods 0.000 description 2
- 230000033764 rhythmic process Effects 0.000 description 2
- 230000028327 secretion Effects 0.000 description 2
- 230000035807 sensation Effects 0.000 description 2
- 235000019615 sensations Nutrition 0.000 description 2
- 210000002435 tendon Anatomy 0.000 description 2
- 230000035922 thirst Effects 0.000 description 2
- 239000003053 toxin Substances 0.000 description 2
- 231100000765 toxin Toxicity 0.000 description 2
- 230000002936 tranquilizing effect Effects 0.000 description 2
- 230000008736 traumatic injury Effects 0.000 description 2
- 201000008297 typhoid fever Diseases 0.000 description 2
- 231100000397 ulcer Toxicity 0.000 description 2
- JWZZKOKVBUJMES-UHFFFAOYSA-N (+-)-Isoprenaline Chemical compound CC(C)NCC(O)C1=CC=C(O)C(O)=C1 JWZZKOKVBUJMES-UHFFFAOYSA-N 0.000 description 1
- UCTWMZQNUQWSLP-VIFPVBQESA-N (R)-adrenaline Chemical compound CNC[C@H](O)C1=CC=C(O)C(O)=C1 UCTWMZQNUQWSLP-VIFPVBQESA-N 0.000 description 1
- 229930182837 (R)-adrenaline Natural products 0.000 description 1
- CWVRJTMFETXNAD-FWCWNIRPSA-N 3-O-Caffeoylquinic acid Natural products O[C@H]1[C@@H](O)C[C@@](O)(C(O)=O)C[C@H]1OC(=O)\C=C\C1=CC=C(O)C(O)=C1 CWVRJTMFETXNAD-FWCWNIRPSA-N 0.000 description 1
- CJIJXIFQYOPWTF-UHFFFAOYSA-N 7-hydroxycoumarin Natural products O1C(=O)C=CC2=CC(O)=CC=C21 CJIJXIFQYOPWTF-UHFFFAOYSA-N 0.000 description 1
- 206010000087 Abdominal pain upper Diseases 0.000 description 1
- 241000251468 Actinopterygii Species 0.000 description 1
- 206010059245 Angiopathy Diseases 0.000 description 1
- 206010002660 Anoxia Diseases 0.000 description 1
- 241000976983 Anoxia Species 0.000 description 1
- 241000208340 Araliaceae Species 0.000 description 1
- 241000132012 Atractylodes Species 0.000 description 1
- 206010006187 Breast cancer Diseases 0.000 description 1
- 208000026310 Breast neoplasm Diseases 0.000 description 1
- PZIRUHCJZBGLDY-UHFFFAOYSA-N Caffeoylquinic acid Natural products CC(CCC(=O)C(C)C1C(=O)CC2C3CC(O)C4CC(O)CCC4(C)C3CCC12C)C(=O)O PZIRUHCJZBGLDY-UHFFFAOYSA-N 0.000 description 1
- 201000009030 Carcinoma Diseases 0.000 description 1
- 208000017897 Carcinoma of esophagus Diseases 0.000 description 1
- 241000700199 Cavia porcellus Species 0.000 description 1
- 206010008111 Cerebral haemorrhage Diseases 0.000 description 1
- 108010023798 Charybdotoxin Proteins 0.000 description 1
- 206010008631 Cholera Diseases 0.000 description 1
- 208000017667 Chronic Disease Diseases 0.000 description 1
- 241000756943 Codonopsis Species 0.000 description 1
- 206010010071 Coma Diseases 0.000 description 1
- 206010010726 Conjunctival oedema Diseases 0.000 description 1
- 244000128583 Coreopsis cardaminifolia Species 0.000 description 1
- 235000005912 Coreopsis cardaminifolia Nutrition 0.000 description 1
- 241001269238 Data Species 0.000 description 1
- 206010011878 Deafness Diseases 0.000 description 1
- 206010012218 Delirium Diseases 0.000 description 1
- 201000004624 Dermatitis Diseases 0.000 description 1
- 206010048768 Dermatosis Diseases 0.000 description 1
- 208000002249 Diabetes Complications Diseases 0.000 description 1
- 206010012655 Diabetic complications Diseases 0.000 description 1
- 208000032928 Dyslipidaemia Diseases 0.000 description 1
- 208000005189 Embolism Diseases 0.000 description 1
- 241000196324 Embryophyta Species 0.000 description 1
- 239000010282 Emodin Substances 0.000 description 1
- 208000008967 Enuresis Diseases 0.000 description 1
- 241000208686 Eucommiaceae Species 0.000 description 1
- 208000010201 Exanthema Diseases 0.000 description 1
- 208000004930 Fatty Liver Diseases 0.000 description 1
- 206010055690 Foetal death Diseases 0.000 description 1
- 208000036119 Frailty Diseases 0.000 description 1
- 206010017577 Gait disturbance Diseases 0.000 description 1
- 206010060710 Galactostasis Diseases 0.000 description 1
- 208000002705 Glucose Intolerance Diseases 0.000 description 1
- 201000005569 Gout Diseases 0.000 description 1
- 208000008899 Habitual abortion Diseases 0.000 description 1
- 102000001554 Hemoglobins Human genes 0.000 description 1
- 108010054147 Hemoglobins Proteins 0.000 description 1
- 206010019708 Hepatic steatosis Diseases 0.000 description 1
- 201000001431 Hyperuricemia Diseases 0.000 description 1
- 208000004044 Hypesthesia Diseases 0.000 description 1
- 208000001953 Hypotension Diseases 0.000 description 1
- 206010061218 Inflammation Diseases 0.000 description 1
- 102000004877 Insulin Human genes 0.000 description 1
- 108090001061 Insulin Proteins 0.000 description 1
- 208000036232 King Evil Diseases 0.000 description 1
- 238000012449 Kunming mouse Methods 0.000 description 1
- 102000007330 LDL Lipoproteins Human genes 0.000 description 1
- 108010007622 LDL Lipoproteins Proteins 0.000 description 1
- 206010023644 Lacrimation increased Diseases 0.000 description 1
- 208000017170 Lipid metabolism disease Diseases 0.000 description 1
- 206010027336 Menstruation delayed Diseases 0.000 description 1
- QYZBCWXZSYTIOY-UHFFFAOYSA-N Mercuric oxide Chemical compound [O-2].[Hg+2] QYZBCWXZSYTIOY-UHFFFAOYSA-N 0.000 description 1
- 206010027514 Metrorrhagia Diseases 0.000 description 1
- 241000218231 Moraceae Species 0.000 description 1
- 241001529936 Murinae Species 0.000 description 1
- 241000699666 Mus <mouse, genus> Species 0.000 description 1
- 208000007101 Muscle Cramp Diseases 0.000 description 1
- 206010028836 Neck pain Diseases 0.000 description 1
- CWVRJTMFETXNAD-KLZCAUPSSA-N Neochlorogenin-saeure Natural products O[C@H]1C[C@@](O)(C[C@@H](OC(=O)C=Cc2ccc(O)c(O)c2)[C@@H]1O)C(=O)O CWVRJTMFETXNAD-KLZCAUPSSA-N 0.000 description 1
- 206010067482 No adverse event Diseases 0.000 description 1
- 208000015914 Non-Hodgkin lymphomas Diseases 0.000 description 1
- 208000008589 Obesity Diseases 0.000 description 1
- 206010030155 Oesophageal carcinoma Diseases 0.000 description 1
- 206010030302 Oliguria Diseases 0.000 description 1
- 235000019082 Osmanthus Nutrition 0.000 description 1
- 241000333181 Osmanthus Species 0.000 description 1
- 201000002451 Overnutrition Diseases 0.000 description 1
- 206010033307 Overweight Diseases 0.000 description 1
- 241000590428 Panacea Species 0.000 description 1
- 235000005035 Panax pseudoginseng ssp. pseudoginseng Nutrition 0.000 description 1
- 240000005373 Panax quinquefolius Species 0.000 description 1
- 206010033645 Pancreatitis Diseases 0.000 description 1
- 208000037273 Pathologic Processes Diseases 0.000 description 1
- 208000018262 Peripheral vascular disease Diseases 0.000 description 1
- NPYPAHLBTDXSSS-UHFFFAOYSA-N Potassium ion Chemical compound [K+] NPYPAHLBTDXSSS-UHFFFAOYSA-N 0.000 description 1
- 206010036790 Productive cough Diseases 0.000 description 1
- 241000219780 Pueraria Species 0.000 description 1
- 206010037660 Pyrexia Diseases 0.000 description 1
- 206010037714 Quadriplegia Diseases 0.000 description 1
- 208000037111 Retinal Hemorrhage Diseases 0.000 description 1
- 206010039101 Rhinorrhoea Diseases 0.000 description 1
- 206010039491 Sarcoma Diseases 0.000 description 1
- 208000006268 Sarcoma 180 Diseases 0.000 description 1
- 206010039897 Sedation Diseases 0.000 description 1
- 206010040943 Skin Ulcer Diseases 0.000 description 1
- 208000013738 Sleep Initiation and Maintenance disease Diseases 0.000 description 1
- 206010049418 Sudden Cardiac Death Diseases 0.000 description 1
- 206010042674 Swelling Diseases 0.000 description 1
- 229930183118 Tanshinone Natural products 0.000 description 1
- 208000024780 Urticaria Diseases 0.000 description 1
- 208000035868 Vascular inflammations Diseases 0.000 description 1
- 208000012886 Vertigo Diseases 0.000 description 1
- 206010047642 Vitiligo Diseases 0.000 description 1
- 241000159213 Zygophyllaceae Species 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 231100000215 acute (single dose) toxicity testing Toxicity 0.000 description 1
- 231100000403 acute toxicity Toxicity 0.000 description 1
- 230000007059 acute toxicity Effects 0.000 description 1
- 238000011047 acute toxicity test Methods 0.000 description 1
- 239000002671 adjuvant Substances 0.000 description 1
- 230000002411 adverse Effects 0.000 description 1
- 230000037006 agalactosis Effects 0.000 description 1
- 238000005054 agglomeration Methods 0.000 description 1
- 238000004220 aggregation Methods 0.000 description 1
- 230000001476 alcoholic effect Effects 0.000 description 1
- 229930013930 alkaloid Natural products 0.000 description 1
- 150000003797 alkaloid derivatives Chemical class 0.000 description 1
- 208000004631 alopecia areata Diseases 0.000 description 1
- 235000001014 amino acid Nutrition 0.000 description 1
- 150000001413 amino acids Chemical class 0.000 description 1
- 230000003321 amplification Effects 0.000 description 1
- 230000036592 analgesia Effects 0.000 description 1
- 208000007502 anemia Diseases 0.000 description 1
- 230000000954 anitussive effect Effects 0.000 description 1
- 230000007953 anoxia Effects 0.000 description 1
- 230000008485 antagonism Effects 0.000 description 1
- 229930185278 anthraglycoside Natural products 0.000 description 1
- 230000003712 anti-aging effect Effects 0.000 description 1
- 230000001093 anti-cancer Effects 0.000 description 1
- 230000001142 anti-diarrhea Effects 0.000 description 1
- 230000000702 anti-platelet effect Effects 0.000 description 1
- 230000002785 anti-thrombosis Effects 0.000 description 1
- 229940124584 antitussives Drugs 0.000 description 1
- 230000004596 appetite loss Effects 0.000 description 1
- 239000007864 aqueous solution Substances 0.000 description 1
- 208000015337 arteriosclerotic cardiovascular disease Diseases 0.000 description 1
- 210000001367 artery Anatomy 0.000 description 1
- 208000010668 atopic eczema Diseases 0.000 description 1
- RJWJHRPNHPHBRN-FKVJWERZSA-N aucubin Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1O[C@H]1[C@@H]2C(CO)=C[C@@H](O)[C@@H]2C=CO1 RJWJHRPNHPHBRN-FKVJWERZSA-N 0.000 description 1
- UTDFQMAXCUGNJR-UHFFFAOYSA-N aucubin Natural products OCC1OC(Oc2ccoc2C3C(O)CCC3O)C(O)C(O)C1O UTDFQMAXCUGNJR-UHFFFAOYSA-N 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 235000019636 bitter flavor Nutrition 0.000 description 1
- 210000001124 body fluid Anatomy 0.000 description 1
- 239000010839 body fluid Substances 0.000 description 1
- 210000000481 breast Anatomy 0.000 description 1
- 201000008275 breast carcinoma Diseases 0.000 description 1
- 230000009172 bursting Effects 0.000 description 1
- 201000011510 cancer Diseases 0.000 description 1
- 230000023852 carbohydrate metabolic process Effects 0.000 description 1
- 235000021256 carbohydrate metabolism Nutrition 0.000 description 1
- 235000014633 carbohydrates Nutrition 0.000 description 1
- 230000000747 cardiac effect Effects 0.000 description 1
- 230000002490 cerebral effect Effects 0.000 description 1
- 206010008118 cerebral infarction Diseases 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- CWVRJTMFETXNAD-JUHZACGLSA-N chlorogenic acid Chemical compound O[C@@H]1[C@H](O)C[C@@](O)(C(O)=O)C[C@H]1OC(=O)\C=C\C1=CC=C(O)C(O)=C1 CWVRJTMFETXNAD-JUHZACGLSA-N 0.000 description 1
- 229940074393 chlorogenic acid Drugs 0.000 description 1
- FFQSDFBBSXGVKF-KHSQJDLVSA-N chlorogenic acid Natural products O[C@@H]1C[C@](O)(C[C@@H](CC(=O)C=Cc2ccc(O)c(O)c2)[C@@H]1O)C(=O)O FFQSDFBBSXGVKF-KHSQJDLVSA-N 0.000 description 1
- 235000001368 chlorogenic acid Nutrition 0.000 description 1
- 201000001883 cholelithiasis Diseases 0.000 description 1
- 235000012000 cholesterol Nutrition 0.000 description 1
- 239000000812 cholinergic antagonist Substances 0.000 description 1
- NZPQWZZXRKZCDU-UHFFFAOYSA-N chrysophanol Natural products Cc1cc(O)c2C(=O)c3c(O)cccc3Oc2c1 NZPQWZZXRKZCDU-UHFFFAOYSA-N 0.000 description 1
- 208000019425 cirrhosis of liver Diseases 0.000 description 1
- BMRSEYFENKXDIS-KLZCAUPSSA-N cis-3-O-p-coumaroylquinic acid Natural products O[C@H]1C[C@@](O)(C[C@@H](OC(=O)C=Cc2ccc(O)cc2)[C@@H]1O)C(=O)O BMRSEYFENKXDIS-KLZCAUPSSA-N 0.000 description 1
- 230000015271 coagulation Effects 0.000 description 1
- 238000005345 coagulation Methods 0.000 description 1
- 238000011443 conventional therapy Methods 0.000 description 1
- 238000001816 cooling Methods 0.000 description 1
- CNVQLPPZGABUCM-LIGYZCPXSA-N ctx toxin Chemical compound C([C@@H](C(=O)N[C@H](C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H](C(=O)N[C@@H](CO)C(=O)N[C@H]1CSSC[C@H]2C(=O)N[C@H](C(N[C@@H](CC(N)=O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@H]3CSSC[C@@H](C(N[C@@H](CC=4C5=CC=CC=C5NC=4)C(=O)N[C@@H](CO)C(=O)N[C@H](C(=O)N[C@@H](CSSC[C@H](NC(=O)[C@H](CCCNC(N)=N)NC3=O)C(=O)N[C@@H](CC=3C=CC(O)=CC=3)C(=O)N[C@@H](CO)C(O)=O)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC=3NC=NC=3)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCNC(N)=N)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N2)C(C)C)=O)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CO)NC(=O)[C@H]([C@@H](C)O)NC(=O)[C@H]([C@@H](C)O)NC1=O)=O)CCSC)C(C)C)[C@@H](C)O)NC(=O)[C@H]1NC(=O)CC1)C1=CC=CC=C1 CNVQLPPZGABUCM-LIGYZCPXSA-N 0.000 description 1
- 230000003013 cytotoxicity Effects 0.000 description 1
- 231100000135 cytotoxicity Toxicity 0.000 description 1
- 230000002354 daily effect Effects 0.000 description 1
- 238000000354 decomposition reaction Methods 0.000 description 1
- 208000013219 diaphoresis Diseases 0.000 description 1
- 235000014113 dietary fatty acids Nutrition 0.000 description 1
- 230000029087 digestion Effects 0.000 description 1
- ZZVUWRFHKOJYTH-UHFFFAOYSA-N diphenhydramine Chemical compound C=1C=CC=CC=1C(OCCN(C)C)C1=CC=CC=C1 ZZVUWRFHKOJYTH-UHFFFAOYSA-N 0.000 description 1
- 208000016097 disease of metabolism Diseases 0.000 description 1
- 239000012153 distilled water Substances 0.000 description 1
- 210000003017 ductus arteriosus Anatomy 0.000 description 1
- 235000013399 edible fruits Nutrition 0.000 description 1
- RHMXXJGYXNZAPX-UHFFFAOYSA-N emodin Chemical compound C1=C(O)C=C2C(=O)C3=CC(C)=CC(O)=C3C(=O)C2=C1O RHMXXJGYXNZAPX-UHFFFAOYSA-N 0.000 description 1
- 238000003912 environmental pollution Methods 0.000 description 1
- 229960005139 epinephrine Drugs 0.000 description 1
- 201000005619 esophageal carcinoma Diseases 0.000 description 1
- 239000000469 ethanolic extract Substances 0.000 description 1
- 210000003414 extremity Anatomy 0.000 description 1
- 208000024756 faint Diseases 0.000 description 1
- 239000000194 fatty acid Substances 0.000 description 1
- 229930195729 fatty acid Natural products 0.000 description 1
- 150000004665 fatty acids Chemical class 0.000 description 1
- 208000010706 fatty liver disease Diseases 0.000 description 1
- 210000003608 fece Anatomy 0.000 description 1
- 230000035558 fertility Effects 0.000 description 1
- 239000003337 fertilizer Substances 0.000 description 1
- 230000001605 fetal effect Effects 0.000 description 1
- 210000003754 fetus Anatomy 0.000 description 1
- 239000000835 fiber Substances 0.000 description 1
- 239000000796 flavoring agent Substances 0.000 description 1
- 235000019634 flavors Nutrition 0.000 description 1
- 235000019264 food flavour enhancer Nutrition 0.000 description 1
- 235000012631 food intake Nutrition 0.000 description 1
- 235000008434 ginseng Nutrition 0.000 description 1
- 210000004907 gland Anatomy 0.000 description 1
- 230000000762 glandular Effects 0.000 description 1
- PCHJSUWPFVWCPO-UHFFFAOYSA-N gold Chemical compound [Au] PCHJSUWPFVWCPO-UHFFFAOYSA-N 0.000 description 1
- 239000010931 gold Substances 0.000 description 1
- 229910052737 gold Inorganic materials 0.000 description 1
- 230000012010 growth Effects 0.000 description 1
- 230000037308 hair color Effects 0.000 description 1
- 208000019622 heart disease Diseases 0.000 description 1
- 230000004217 heart function Effects 0.000 description 1
- 230000000004 hemodynamic effect Effects 0.000 description 1
- 230000002607 hemopoietic effect Effects 0.000 description 1
- 208000006454 hepatitis Diseases 0.000 description 1
- 231100000283 hepatitis Toxicity 0.000 description 1
- 208000002672 hepatitis B Diseases 0.000 description 1
- 229940088597 hormone Drugs 0.000 description 1
- 239000005556 hormone Substances 0.000 description 1
- 208000013403 hyperactivity Diseases 0.000 description 1
- 230000003516 hyperlipidaemic effect Effects 0.000 description 1
- 208000034783 hypoesthesia Diseases 0.000 description 1
- 230000002218 hypoglycaemic effect Effects 0.000 description 1
- 210000003026 hypopharynx Anatomy 0.000 description 1
- 208000021822 hypotensive Diseases 0.000 description 1
- 230000007954 hypoxia Effects 0.000 description 1
- 201000001881 impotence Diseases 0.000 description 1
- 230000006872 improvement Effects 0.000 description 1
- 238000001727 in vivo Methods 0.000 description 1
- 208000015181 infectious disease Diseases 0.000 description 1
- 230000002458 infectious effect Effects 0.000 description 1
- 230000004054 inflammatory process Effects 0.000 description 1
- 230000002401 inhibitory effect Effects 0.000 description 1
- 230000005764 inhibitory process Effects 0.000 description 1
- 230000000977 initiatory effect Effects 0.000 description 1
- 238000002347 injection Methods 0.000 description 1
- 239000007924 injection Substances 0.000 description 1
- 206010022437 insomnia Diseases 0.000 description 1
- 238000007689 inspection Methods 0.000 description 1
- 229940125396 insulin Drugs 0.000 description 1
- 230000000968 intestinal effect Effects 0.000 description 1
- 210000000936 intestine Anatomy 0.000 description 1
- 238000011835 investigation Methods 0.000 description 1
- 230000001788 irregular Effects 0.000 description 1
- 229940039009 isoproterenol Drugs 0.000 description 1
- 230000003907 kidney function Effects 0.000 description 1
- 230000004317 lacrimation Effects 0.000 description 1
- 150000002596 lactones Chemical class 0.000 description 1
- 210000002429 large intestine Anatomy 0.000 description 1
- 208000032839 leukemia Diseases 0.000 description 1
- 230000037356 lipid metabolism Effects 0.000 description 1
- 210000005229 liver cell Anatomy 0.000 description 1
- 230000003908 liver function Effects 0.000 description 1
- 235000021142 long-term diet Nutrition 0.000 description 1
- 231100001252 long-term toxicity Toxicity 0.000 description 1
- 208000019017 loss of appetite Diseases 0.000 description 1
- 235000021266 loss of appetite Nutrition 0.000 description 1
- 210000003141 lower extremity Anatomy 0.000 description 1
- 208000025036 lymphosarcoma Diseases 0.000 description 1
- 231100000682 maximum tolerated dose Toxicity 0.000 description 1
- 230000004630 mental health Effects 0.000 description 1
- 208000030159 metabolic disease Diseases 0.000 description 1
- 230000027939 micturition Effects 0.000 description 1
- 230000001617 migratory effect Effects 0.000 description 1
- 235000013336 milk Nutrition 0.000 description 1
- 210000004080 milk Anatomy 0.000 description 1
- 239000008267 milk Substances 0.000 description 1
- 208000010125 myocardial infarction Diseases 0.000 description 1
- 208000031225 myocardial ischemia Diseases 0.000 description 1
- 208000010753 nasal discharge Diseases 0.000 description 1
- 231100000252 nontoxic Toxicity 0.000 description 1
- 230000003000 nontoxic effect Effects 0.000 description 1
- 238000003199 nucleic acid amplification method Methods 0.000 description 1
- 235000015097 nutrients Nutrition 0.000 description 1
- 230000035764 nutrition Effects 0.000 description 1
- 235000016709 nutrition Nutrition 0.000 description 1
- 235000008935 nutritious Nutrition 0.000 description 1
- 235000020824 obesity Nutrition 0.000 description 1
- 229940126701 oral medication Drugs 0.000 description 1
- 230000008520 organization Effects 0.000 description 1
- 238000000643 oven drying Methods 0.000 description 1
- 235000020823 overnutrition Nutrition 0.000 description 1
- 230000003119 painkilling effect Effects 0.000 description 1
- 210000000496 pancreas Anatomy 0.000 description 1
- 230000032696 parturition Effects 0.000 description 1
- 231100000915 pathological change Toxicity 0.000 description 1
- 230000036285 pathological change Effects 0.000 description 1
- 230000001575 pathological effect Effects 0.000 description 1
- 230000009054 pathological process Effects 0.000 description 1
- 230000036513 peripheral conductance Effects 0.000 description 1
- 230000002093 peripheral effect Effects 0.000 description 1
- 239000000575 pesticide Substances 0.000 description 1
- FFWOKTFYGVYKIR-UHFFFAOYSA-N physcion Chemical compound C1=C(C)C=C2C(=O)C3=CC(OC)=CC(O)=C3C(=O)C2=C1O FFWOKTFYGVYKIR-UHFFFAOYSA-N 0.000 description 1
- OISYIJRGMYJBRH-UHFFFAOYSA-N physcione Natural products COc1cc(O)c2C(=O)c3ccc(O)cc3C(=O)c2c1 OISYIJRGMYJBRH-UHFFFAOYSA-N 0.000 description 1
- 230000035790 physiological processes and functions Effects 0.000 description 1
- 210000002826 placenta Anatomy 0.000 description 1
- 206010036067 polydipsia Diseases 0.000 description 1
- XAEFZNCEHLXOMS-UHFFFAOYSA-M potassium benzoate Chemical compound [K+].[O-]C(=O)C1=CC=CC=C1 XAEFZNCEHLXOMS-UHFFFAOYSA-M 0.000 description 1
- 229910001414 potassium ion Inorganic materials 0.000 description 1
- 201000009104 prediabetes syndrome Diseases 0.000 description 1
- 239000003755 preservative agent Substances 0.000 description 1
- 230000002335 preservative effect Effects 0.000 description 1
- 230000002265 prevention Effects 0.000 description 1
- 230000001681 protective effect Effects 0.000 description 1
- 235000018102 proteins Nutrition 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 230000009325 pulmonary function Effects 0.000 description 1
- 238000010926 purge Methods 0.000 description 1
- 238000000746 purification Methods 0.000 description 1
- 239000010023 qingre quyu Substances 0.000 description 1
- 210000000664 rectum Anatomy 0.000 description 1
- 230000009467 reduction Effects 0.000 description 1
- 230000008929 regeneration Effects 0.000 description 1
- 238000011069 regeneration method Methods 0.000 description 1
- 230000003014 reinforcing effect Effects 0.000 description 1
- 230000002040 relaxant effect Effects 0.000 description 1
- 230000029058 respiratory gaseous exchange Effects 0.000 description 1
- 230000002441 reversible effect Effects 0.000 description 1
- 210000003296 saliva Anatomy 0.000 description 1
- 229920006395 saturated elastomer Polymers 0.000 description 1
- 238000009738 saturating Methods 0.000 description 1
- 208000037921 secondary disease Diseases 0.000 description 1
- 230000036280 sedation Effects 0.000 description 1
- 238000004062 sedimentation Methods 0.000 description 1
- 201000000849 skin cancer Diseases 0.000 description 1
- 201000008261 skin carcinoma Diseases 0.000 description 1
- 208000017520 skin disease Diseases 0.000 description 1
- 231100000019 skin ulcer Toxicity 0.000 description 1
- 239000002002 slurry Substances 0.000 description 1
- 210000000813 small intestine Anatomy 0.000 description 1
- 230000035943 smell Effects 0.000 description 1
- 230000000391 smoking effect Effects 0.000 description 1
- 210000002460 smooth muscle Anatomy 0.000 description 1
- 230000002048 spasmolytic effect Effects 0.000 description 1
- 230000021595 spermatogenesis Effects 0.000 description 1
- 230000005982 spleen dysfunction Effects 0.000 description 1
- 230000002269 spontaneous effect Effects 0.000 description 1
- 210000003802 sputum Anatomy 0.000 description 1
- 208000024794 sputum Diseases 0.000 description 1
- 231100000240 steatosis hepatitis Toxicity 0.000 description 1
- 230000004936 stimulating effect Effects 0.000 description 1
- 230000004206 stomach function Effects 0.000 description 1
- 238000007920 subcutaneous administration Methods 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 239000013589 supplement Substances 0.000 description 1
- 210000004243 sweat Anatomy 0.000 description 1
- 230000035900 sweating Effects 0.000 description 1
- 230000009885 systemic effect Effects 0.000 description 1
- CEIZFXOZIQNICU-UHFFFAOYSA-N tenuazonic acid Chemical compound CCC(C)C1NC(=O)C(C(C)=O)=C1O CEIZFXOZIQNICU-UHFFFAOYSA-N 0.000 description 1
- 210000001519 tissue Anatomy 0.000 description 1
- 230000001256 tonic effect Effects 0.000 description 1
- 230000009466 transformation Effects 0.000 description 1
- 230000008733 trauma Effects 0.000 description 1
- ORHBXUUXSCNDEV-UHFFFAOYSA-N umbelliferone Chemical compound C1=CC(=O)OC2=CC(O)=CC=C21 ORHBXUUXSCNDEV-UHFFFAOYSA-N 0.000 description 1
- HFTAFOQKODTIJY-UHFFFAOYSA-N umbelliferone Natural products Cc1cc2C=CC(=O)Oc2cc1OCC=CC(C)(C)O HFTAFOQKODTIJY-UHFFFAOYSA-N 0.000 description 1
- 210000001113 umbilicus Anatomy 0.000 description 1
- 150000004670 unsaturated fatty acids Chemical class 0.000 description 1
- 235000021122 unsaturated fatty acids Nutrition 0.000 description 1
- 210000003932 urinary bladder Anatomy 0.000 description 1
- 210000004291 uterus Anatomy 0.000 description 1
- 230000006438 vascular health Effects 0.000 description 1
- 230000003639 vasoconstrictive effect Effects 0.000 description 1
- 210000003462 vein Anatomy 0.000 description 1
- 231100000889 vertigo Toxicity 0.000 description 1
- 239000000341 volatile oil Substances 0.000 description 1
- 210000004916 vomit Anatomy 0.000 description 1
- 238000010792 warming Methods 0.000 description 1
- 230000003442 weekly effect Effects 0.000 description 1
- 239000010365 xinkeshu Substances 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/898—Orchidaceae (Orchid family)
- A61K36/8988—Gastrodia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
- A61K35/36—Skin; Hair; Nails; Sebaceous glands; Cerumen; Epidermis; Epithelial cells; Keratinocytes; Langerhans cells; Ectodermal cells
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/56—Materials from animals other than mammals
- A61K35/62—Leeches; Worms, e.g. cestodes, tapeworms, nematodes, roundworms, earth worms, ascarids, filarias, hookworms, trichinella or taenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/56—Materials from animals other than mammals
- A61K35/63—Arthropods
- A61K35/646—Arachnids, e.g. spiders, scorpions, ticks or mites
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/06—Fungi, e.g. yeasts
- A61K36/07—Basidiomycota, e.g. Cryptococcus
- A61K36/076—Poria
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/16—Ginkgophyta, e.g. Ginkgoaceae (Ginkgo family)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/21—Amaranthaceae (Amaranth family), e.g. pigweed, rockwort or globe amaranth
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/23—Apiaceae or Umbelliferae (Carrot family), e.g. dill, chervil, coriander or cumin
- A61K36/232—Angelica
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/23—Apiaceae or Umbelliferae (Carrot family), e.g. dill, chervil, coriander or cumin
- A61K36/236—Ligusticum (licorice-root)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/23—Apiaceae or Umbelliferae (Carrot family), e.g. dill, chervil, coriander or cumin
- A61K36/237—Notopterygium
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/25—Araliaceae (Ginseng family), e.g. ivy, aralia, schefflera or tetrapanax
- A61K36/258—Panax (ginseng)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
- A61K36/282—Artemisia, e.g. wormwood or sagebrush
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
- A61K36/284—Atractylodes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
- A61K36/285—Aucklandia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
- A61K36/286—Carthamus (distaff thistle)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/46—Eucommiaceae (Eucommia family), e.g. hardy rubber tree
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
- A61K36/482—Cassia, e.g. golden shower tree
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
- A61K36/486—Millettia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
- A61K36/488—Pueraria (kudzu)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/53—Lamiaceae or Labiatae (Mint family), e.g. thyme, rosemary or lavender
- A61K36/537—Salvia (sage)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/60—Moraceae (Mulberry family), e.g. breadfruit or fig
- A61K36/605—Morus (mulberry)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/70—Polygonaceae (Buckwheat family), e.g. spineflower or dock
- A61K36/704—Polygonum, e.g. knotweed
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/73—Rosaceae (Rose family), e.g. strawberry, chokeberry, blackberry, pear or firethorn
- A61K36/734—Crataegus (hawthorn)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/74—Rubiaceae (Madder family)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/75—Rutaceae (Rue family)
- A61K36/752—Citrus, e.g. lime, orange or lemon
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/08—Solutions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
- A61K9/2059—Starch, including chemically or physically modified derivatives; Amylose; Amylopectin; Dextrin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/4841—Filling excipients; Inactive ingredients
- A61K9/4858—Organic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/30—Extraction of the material
- A61K2236/33—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/30—Extraction of the material
- A61K2236/33—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones
- A61K2236/331—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones using water, e.g. cold water, infusion, tea, steam distillation or decoction
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/30—Extraction of the material
- A61K2236/33—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones
- A61K2236/333—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones using mixed solvents, e.g. 70% EtOH
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/30—Extraction of the material
- A61K2236/39—Complex extraction schemes, e.g. fractionation or repeated extraction steps
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/50—Methods involving additional extraction steps
- A61K2236/51—Concentration or drying of the extract, e.g. Lyophilisation, freeze-drying or spray-drying
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/50—Methods involving additional extraction steps
- A61K2236/53—Liquid-solid separation, e.g. centrifugation, sedimentation or crystallization
Landscapes
- Health & Medical Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Biotechnology (AREA)
- Mycology (AREA)
- Medical Informatics (AREA)
- Microbiology (AREA)
- Botany (AREA)
- Alternative & Traditional Medicine (AREA)
- Tropical Medicine & Parasitology (AREA)
- Cell Biology (AREA)
- General Chemical & Material Sciences (AREA)
- Biomedical Technology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Biochemistry (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Insects & Arthropods (AREA)
- Dermatology (AREA)
- Molecular Biology (AREA)
- Developmental Biology & Embryology (AREA)
- Immunology (AREA)
- Virology (AREA)
- Zoology (AREA)
- Gastroenterology & Hepatology (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
The invention provides a pharmaceutical composition capable of softening blood vessels. The pharmaceutical composition is prepared from leaves of crataegus pinnatifida var. major, radix salvia miltiorrhiza, scorpions, squama manis, radix achyranthis bidentatae, rhizoma et radix notopterygii, rhizoma atractylodis macrocephalae, tribulus terrestris, radix notoginseng, capillary wormwood herb, white mulberry root-bark, caulis spatholobi, ramulus uncariae cum uncis, flos carthami, Chinese crossostepium leaves, poria cocos, snow lotus herb, folium cortex eucommiae, radix angelica sinensis, rhizoma chuanxiong, pericarpium citri reticulatae, rhizoma polygoni cuspidate, lumbricus, herba portulacae, folium ginkgo, kudzuvine roots, semen cassia, fructus crataegi and rhizoma gastrodiae. According to the pharmaceutical composition, compatibility is in compliance with the 'monarch, minster, assistant and guide' principle of traditional Chinese medicine, gives prominence to the key points and is comprehensive and reasonable, by orally taking the medicine, the viscera functions can be regulated, blood fat can be lowered, the blood vessels can be softened, the blood quality can be made to be clear and thin, the blood flow activity can be improved, and the blood vessel softening effect is obvious; in addition, the raw materials are rich, a preparation technology is simple, no toxic or side effect is generated, the price is low, and the good application prospect on softening the blood vessels and treating and preventing high blood pressure, high blood fat and high blood sugar, especially the high blood fat is achieved.
Description
Technical field
The invention belongs to pharmaceutical technology field, relate to a kind of Chinese medicine composition, be specifically related to pharmaceutical composition and the application thereof of a kind of vessel softening。
Background technology
Due to economical day by day flourishing, the continuous lifting of modern's living standard, cause people too much have deep love for enjoy, do not notice that the life style of oneself, behavioural habits, diet are had a liking for, thus the disease caused。Society with fast rhythm lives, the operating pressure of keen competition, the physical and mental health of modern is caused serious threat, unreasonable plus long-term diet, that is: essence grain replaces coarse grain completely, the pesticide that remains in substantial amounts of three-hypers (high heat, high protein, higher fatty acid), the absorption of more than three (preservative is many, flavour enhancer is many, hormone many) food and food, chemical fertilizer stockpiling in vivo, add air, pollution of waterhead and quantity of motion less than normal, the fat affluenza just having become city family with diabetes。Being what has statistics about three-hypers, in the Chinese ten big causes of death, the mortality rate relevant to metabolic disease is just up to 35.7%, and the death toll relevant to " three high " also accounts for the 27% of total death toll。" three-hypers disease " refers to hypertension, hyperglycemia (diabetes) and hyperlipidemia。Hyperlipidemia can cause blood vessel embolism;Hypertension can cause cerebral hemorrhage and rupture of blood vessel in brain;Hyperglycemia can cause diabetes。Generally along with obesity。They are that " affluenza " is derived from modern society, it is possible to individualism, it is also possible to interrelated。As: diabetes patient is easy to suffer from hypertension or hyperlipidemia simultaneously, and hyperlipidemia is the principal element of arteriosclerosis formation and development, and arteriosclerotic's blood vessel elasticity difference aggravation blood pressure raises, so the later stage all defines " three-hypers disease "。World Health Organization (WHO) once clearly proposed, it is prevented that the first line of defence of cardiovascular diseases reduces " three high " exactly and controls " three high "。A lot of diabetes patients are with hyperlipemia, and therefore diabetes and hyperlipemia, people generally call that sister is sick, and think that hyperlipidemia is the secondary disease of diabetes。The diabetic of about 40% has disorders of lipid metabolism according to statistics。It is characterized in that triglyceride increases to reduce with high density lipoprotein。
Hyperlipidemia is a kind of systemic disease, and a large amount of research datas show, hyperlipidemia is apoplexy, coronary heart disease, myocardial infarction, cardiac sudden death independently important risk factor。Additionally, hyperlipidemia is also the important risk factor promoting hypertension, impaired glucose tolerance, diabetes。Hyperlipidemia can also result in fatty liver, liver cirrhosis, cholelithiasis, pancreatitis, retinal hemorrhage, blind, peripheral vascular disease, limping, hyperuricemia。
Between nearly 20 years, the food consumption of people and diet structure there occurs very big change, and the sickness rate that the most active effects thus brought is exactly hyperlipidemia constantly promotes, and progressively occurs becoming younger。City white collar rhythm of life is fast, and operating pressure is big, and diet is irregular, lacks motion, and the people of about 40% is hyperlipidemia。According to statistics, China's hyperlipidemia number of patients is up to 1.6 hundred million, and expert estimates, in the middle of the adult in more than 30 years old, the whole nation, the sickness rate of hyperlipidemia is at about 10%-20%, and hyperlipemia number is up to 90,000,000。Investigation display, China has 250 ten thousand to 300 ten thousand people to die from cardiovascular diseases every year, and this kind of disease has become harm China city and the major causes of death of rural population health。Talking about cardiovascular disease, a lot of people know relevant with hypertension, but it practice, hide at us internal, the moment threatens also more hidden, more severe " killer " of our vascular health, and it is exactly hyperlipidemia。Expert points out, dyslipidemia is one of important risk factor of the medium cardiovascular and cerebrovascular disease of coronary heart disease, heart infarction and ischemic cerebral apoplexy。
Young generation " senile disease " is increased year by year in recent years。Arteriosclerotic cardiovascular and cerebrovascular disease occurs gradually, many and bad life style, the accumulation environmental pollution of vivotoxin causes that hyperlipidemia cohesion is relevant, life, work strain, smoking, excessive drinking, overnutrition, blood thickness, abnormal composition (toxin) etc. in blood, severe overweight, form arteriosclerosis, the thrombosis at vascular inflammation and initial stage, mid-term, the dysemia phase, teenager is cradle even, mid-term, angiopathy becomes the hemodynamic change phase, the young and the middle aged can occur, late period, stage of exhaustion (a sick phase) angiemphraxis of visceral organ injury phase or life is serious, cardiovascular and cerebrovascular disease is caused more than 50%, peripheral vessels occurs, form serious hypertension, severe patient life exhaustion。
Sclerosis of blood vessels blood thickness is the source of ten thousand diseases。The arteriosclerosis that thus causes, blood high viscosity syndrome, heart disease, heart infarction, cerebral infarction, apoplexy, hypertension, diabetes, tumor etc. are in being gradually increasing trend。It is especially prominent that high blood viscosity thick initiation three-hypers, high blood viscosity cause hyperlipidemia, high blood viscosity to cause hypertension, high blood viscosity to accelerate diabetic complication。Western medicine current therapeutic effect in treatment sclerosis of blood vessels blood thickness is unsatisfactory, price is high, and generally all it is attended by serious side effect, have a strong impact on the healthy of patient, Chinese medicine has unique advantage because its side effect is little in treating such chronic disease, but lacks effective prescription of vessel softening at present。
Summary of the invention
The present invention is directed to weak point of the prior art, it is provided that the pharmaceutical composition of a kind of vessel softening and application thereof, this pharmaceutical composition technique is simple, and cost is low, has no side effect, and has significant curative effect in vessel softening。
The above-mentioned purpose of the present invention is realized by following technical proposals:
The pharmaceutical composition of a kind of vessel softening, the crude drug of described pharmaceutical composition is made up of crataegus pin natifida var. Major leaf, Radix Salviae Miltiorrhizae, Scorpio, Squama Manis, Radix Achyranthis Bidentatae, Rhizoma Et Radix Notopterygii, the Rhizoma Atractylodis Macrocephalae, Fructus Atriplicis Sibiricae, Radix Notoginseng, Herba Artemisiae Scopariae, Cortex Mori, Caulis Spatholobi, Ramulus Uncariae Cum Uncis, Flos Carthami, Folium Crossostephii Chinensis, Poria, Herba Saussureae Involueratae, Folium Eucommiae, Radix Angelicae Sinensis, Rhizoma Chuanxiong, Pericarpium Citri Reticulatae, Rhizoma Polygoni Cuspidati, Pheretima, Herba Portulacae, Folium Ginkgo, Radix Puerariae, Semen Cassiae, Fructus Crataegi, Rhizoma Gastrodiae。
In a preferred embodiment, make described pharmaceutical composition raw material composition and parts by weight be: crataegus pin natifida var. Major leaf 12-20 part, Scorpio 10-16 part, Radix Angelicae Sinensis 3-8 part, Squama Manis 5-12 part, Radix Achyranthis Bidentatae 12-17 part, Radix Salviae Miltiorrhizae 7-12 part, Flos Carthami 4-9 part, Rhizoma Atractylodis Macrocephalae 15-20 part, Fructus Atriplicis Sibiricae 10-15 part, Herba Artemisiae Scopariae 8-12 part, Cortex Mori 2-5 part, Rhizoma Et Radix Notopterygii 3-7 part, Caulis Spatholobi 11-14 part, Ramulus Uncariae Cum Uncis 9-15 part, Rhizoma Chuanxiong 3-6 part, Folium Crossostephii Chinensis 8-13 part, Herba Saussureae Involueratae 3-5 part, Folium Eucommiae 1-3 part, Pericarpium Citri Reticulatae 5-10 part, Radix Notoginseng 5-10 part, Rhizoma Polygoni Cuspidati 13-16 part, Pheretima 3-10 part, Herba Portulacae 8-13 part, Folium Ginkgo 3-5 part, Poria 1-3 part, Radix Puerariae 5-10 part, Semen Cassiae 3-6 part, Fructus Crataegi 8-13 part, Rhizoma Gastrodiae 3-5 part。
In a preferred embodiment, make described pharmaceutical composition raw material composition and parts by weight be: 12 parts of crataegus pin natifida var. Major leaf, Scorpio 16 parts, Radix Angelicae Sinensis 3 parts, Squama Manis 12 parts, Radix Achyranthis Bidentatae 12 parts, Radix Salviae Miltiorrhizae 10 parts, 9 parts of Flos Carthami, the Rhizoma Atractylodis Macrocephalae 15 parts, Fructus Atriplicis Sibiricae 15 parts, Herba Artemisiae Scopariae 8 parts, Cortex Mori 5 parts, Rhizoma Et Radix Notopterygii 3 parts, Caulis Spatholobi 14 parts, Ramulus Uncariae Cum Uncis 9 parts, Rhizoma Chuanxiong 6 parts, Folium Crossostephii Chinensis 8 parts, Herba Saussureae Involueratae 5 parts, Folium Eucommiae 1 part, Pericarpium Citri Reticulatae 10 parts, Radix Notoginseng 5 parts, Rhizoma Polygoni Cuspidati 16 parts, Pheretima 10 parts, Herba Portulacae 8 parts, Folium Ginkgo 5 parts, 1 part of Poria, Radix Puerariae 10 parts, Semen Cassiae 6 parts, Fructus Crataegi 8 parts, 3 parts of Rhizoma Gastrodiae。
In a preferred embodiment, make described pharmaceutical composition raw material composition and parts by weight be: 20 parts of crataegus pin natifida var. Major leaf, Scorpio 10 parts, Radix Angelicae Sinensis 8 parts, Squama Manis 5 parts, Radix Achyranthis Bidentatae 17 parts, Radix Salviae Miltiorrhizae 12 parts, 4 parts of Flos Carthami, the Rhizoma Atractylodis Macrocephalae 20 parts, Fructus Atriplicis Sibiricae 10 parts, Herba Artemisiae Scopariae 12 parts, Cortex Mori 2 parts, Rhizoma Et Radix Notopterygii 7 parts, Caulis Spatholobi 11 parts, Ramulus Uncariae Cum Uncis 15 parts, Rhizoma Chuanxiong 3 parts, Folium Crossostephii Chinensis 13 parts, Herba Saussureae Involueratae 3 parts, Folium Eucommiae 3 parts, Pericarpium Citri Reticulatae 5 parts, Radix Notoginseng 10 parts, Rhizoma Polygoni Cuspidati 13 parts, Pheretima 3 parts, Herba Portulacae 13 parts, Folium Ginkgo 3 parts, 3 parts of Poria, Radix Puerariae 5 parts, Semen Cassiae 4 parts, Fructus Crataegi 10 parts, 4 parts of Rhizoma Gastrodiae。
In a preferred embodiment, make described pharmaceutical composition raw material composition and parts by weight be: 13 parts of crataegus pin natifida var. Major leaf, Scorpio 11 parts, Radix Angelicae Sinensis 4 parts, Squama Manis 6 parts, Radix Achyranthis Bidentatae 13 parts, Radix Salviae Miltiorrhizae 7 parts, 5 parts of Flos Carthami, the Rhizoma Atractylodis Macrocephalae 18 parts, Fructus Atriplicis Sibiricae 11 parts, Herba Artemisiae Scopariae 9 parts, Cortex Mori 4 parts, Rhizoma Et Radix Notopterygii 6 parts, Caulis Spatholobi 12 parts, Ramulus Uncariae Cum Uncis 13 parts, Rhizoma Chuanxiong 4 parts, Folium Crossostephii Chinensis 9 parts, Herba Saussureae Involueratae 4 parts, Folium Eucommiae 2 parts, Pericarpium Citri Reticulatae 6 parts, Radix Notoginseng 6 parts, Rhizoma Polygoni Cuspidati 14 parts, Pheretima 5 parts, Herba Portulacae 10 parts, Folium Ginkgo 4 parts, 2 parts of Poria, Radix Puerariae 6 parts, Semen Cassiae 5 parts, Fructus Crataegi 12 parts, 3 parts of Rhizoma Gastrodiae。
In a preferred embodiment, make described pharmaceutical composition raw material composition and parts by weight be: 17 parts of crataegus pin natifida var. Major leaf, Scorpio 15 parts, Radix Angelicae Sinensis 7 parts, Squama Manis 11 parts, Radix Achyranthis Bidentatae 16 parts, Radix Salviae Miltiorrhizae 8 parts, 8 parts of Flos Carthami, the Rhizoma Atractylodis Macrocephalae 16 parts, Fructus Atriplicis Sibiricae 14 parts, Herba Artemisiae Scopariae 11 parts, Cortex Mori 3 parts, Rhizoma Et Radix Notopterygii 5 parts, Caulis Spatholobi 13 parts, Ramulus Uncariae Cum Uncis 14 parts, Rhizoma Chuanxiong 5 parts, Folium Crossostephii Chinensis 12 parts, Herba Saussureae Involueratae 3 parts, Folium Eucommiae 1 part, Pericarpium Citri Reticulatae 10 parts, Radix Notoginseng 9 parts, Rhizoma Polygoni Cuspidati 13 parts, Pheretima 7 parts, Herba Portulacae 11 parts, Folium Ginkgo 3 parts, 1 part of Poria, Radix Puerariae 10 parts, Semen Cassiae 4 parts, Fructus Crataegi 11 parts, 4 parts of Rhizoma Gastrodiae。
In a preferred embodiment, make described pharmaceutical composition raw material composition and parts by weight be: 15 parts of crataegus pin natifida var. Major leaf, Scorpio 12 parts, Radix Angelicae Sinensis 5 parts, Squama Manis 9 parts, Radix Achyranthis Bidentatae 15 parts, Radix Salviae Miltiorrhizae 9 parts, 7 parts of Flos Carthami, the Rhizoma Atractylodis Macrocephalae 19 parts, Fructus Atriplicis Sibiricae 13 parts, Herba Artemisiae Scopariae 10 parts, Cortex Mori 4 parts, Rhizoma Et Radix Notopterygii 4 parts, Caulis Spatholobi 11 parts, Ramulus Uncariae Cum Uncis 11 parts, Rhizoma Chuanxiong 5 parts, Folium Crossostephii Chinensis 10 parts, Herba Saussureae Involueratae 5 parts, Folium Eucommiae 3 parts, Pericarpium Citri Reticulatae 8 parts, Radix Notoginseng 8 parts, Rhizoma Polygoni Cuspidati 14 parts, Pheretima 9 parts, Herba Portulacae 12 parts, Folium Ginkgo 5 parts, 3 parts of Poria, Radix Puerariae 8 parts, Semen Cassiae 6 parts, Fructus Crataegi 9 parts, 5 parts of Rhizoma Gastrodiae。
In a preferred embodiment, make described pharmaceutical composition raw material composition and parts by weight be: 19 parts of crataegus pin natifida var. Major leaf, Scorpio 14 parts, Radix Angelicae Sinensis 6 parts, Squama Manis 7 parts, Radix Achyranthis Bidentatae 14 parts, Radix Salviae Miltiorrhizae 9 parts, 6 parts of Flos Carthami, the Rhizoma Atractylodis Macrocephalae 17 parts, Fructus Atriplicis Sibiricae 13 parts, Herba Artemisiae Scopariae 10 parts, Cortex Mori 4 parts, Rhizoma Et Radix Notopterygii 4 parts, Caulis Spatholobi 11 parts, Ramulus Uncariae Cum Uncis 11 parts, Rhizoma Chuanxiong 5 parts, Folium Crossostephii Chinensis 10 parts, Herba Saussureae Involueratae 5 parts, Folium Eucommiae 3 parts, Pericarpium Citri Reticulatae 8 parts, Radix Notoginseng 8 parts, Rhizoma Polygoni Cuspidati 14 parts, Pheretima 4 parts, Herba Portulacae 9 parts, Folium Ginkgo 5 parts, 3 parts of Poria, Radix Puerariae 8 parts, Semen Cassiae 3 parts, Fructus Crataegi 8 parts, 5 parts of Rhizoma Gastrodiae。
In a preferred embodiment, described Chinese medicine composition is prepared in following manner:
(1) each medical material of components by weight percent in the arbitrary described pharmaceutical composition of claim 2-8 is taken, add in the ethanol of 5-10 times amount and soak 1-2 hour, heating extraction 2 times, each 1-2 hour, removes supernatant, united extraction liquid, 100-120 order filters, the ultrafiltration post ultrafiltration that molecular weight is 5000-10000 then through damming, the extractum of 1.36 when ultrafiltrate concentrating under reduced pressure relative density is 80 DEG C, heating is concentrated into paste, stand for standby use;
(2) being put in 10 times amount water by the medicinal residues that ethanol extraction is crossed, be then placed in extraction pot heated and boiled 1 hour, filter, filtrate is standby;Filtering residue adds water, second time heating, boils 45 minutes, filters, and filtrate is standby;
(3) 2 filtrates in step (2) being combined, by filtered through gauze, add 50-60% ethanol in residue, 60 DEG C-70 DEG C are continued lixiviate 2h, every 10min and stir once, and filtered through gauze merges lixiviating solution, is condensed into pasty state;
(4) the pastel decompression recycling ethanol that step (1) paste that obtains of concentration and step (3) obtained to be concentrated into liquor strength be 0.6-0.7g crude drug/mL, after sucking filtration, the relative density of filtrate is about 1.0-1.1 when 20 DEG C;It is centrifuged under the rotating speed of 3000r/min;At 60 DEG C of-80 DEG C of spray drying, obtain dry extract;
(5) dry extract that step (4) prepares is pulverized, add suitable amount of sucrose, dextrin mixing, with ethanol for wetting agent, granulate, dry, granulate, granule can be prepared;Or the dry extract that step (4) prepares be dry, pulverize, make powder;Or dry extract step (4) prepared is pulverized, add appropriate micropowder silica gel, α-galactose mixing, with ethanol for wetting agent, granulate, dry, granulate, encapsulated, prepare capsule;Or dry extract step (4) prepared is pulverized, add suitable amount of sucrose, dextrin mixing, with ethanol for wetting agent, granulate, dry, granulate, tabletting, prepare tablet;Or to above-mentioned steps (4) obtain centrifugal after concentrated solution in add suitable amount of sucrose, essence mixing, sterilizing, fill, prepare medicinal liquid agent。
The invention still further relates to the application in vessel softening medicine of a kind of described pharmaceutical composition。
The pharmaceutical composition of vessel softening provided by the present invention, it gives full play to the property of medicine of each component with common Chinese herbal medicine for raw material:
Contained by crataegus pin natifida var. Major leaf, crataegus pin natifida var. Major leaf flavonoids has pharmacological action widely, is particularly useful for cardiovascular system。Experimentation shows, crataegus pin natifida var. Major leaf flavonoids has blood pressure lowering, reduces peripheral vascular resistance, coronary artery dilator, increase coronary flow, reduce myocardial oxygen consumption, heart tonifying, increase cardiac output, resist myocardial ischemia, and antiplatelet aggregation, improves hemorheological property, eliminates oxygen-derived free radicals, drops the pharmacological actions such as excellent and constitution, enhancing hypoxia-bearing capability and diuresis。It is all safe and effective for being clinically used for preventing and treating angina pectoris, hypertension, arrhythmia and hyperlipemia, atherosclerosis etc., is worthy of popularization。Crataegus pin natifida var. Major leaf is very abundant at China various places particularly Resources of The West Area In China, has significantly high Development volue。
Radix Salviae Miltiorrhizae, bitter, it is slightly cold。GUIXIN, Liver Channel。Stasis-dispelling and pain-killing, promoting blood circulation to restore menstrual flow, clear away heart-fire relieving restlessness。For menoxenia, amenorrhea dysmenorrhea, lump in the abdomen, chest and abdomen twinge, pyretic arthralgia pain, skin infection swells and ache, dysphoria and insomnia。For costa sternales hypochondriac pain, rheumatic arthralgia, lump in the abdomen lumps, and skin infection swells and ache, and tumbling down is grieved, menoxenia, amenorrhea dysmenorrhea, puerperal stasis of blood pain etc.。Treatment costa sternales pain, lump in the abdomen caking, and menoxenia, amenorrhea dysmenorrhoea has good effect。" detailed outline " carries: Radix Salviae Miltiorrhizae, and by " the sensible opinion of married woman " cloud, SIWU TANG controls gynecopathy, pays no attention to antenatal puerperal, how many through water, and all generally applicable, only taste Radix Salviae Miltiorrhizae dissipates, and cures mainly same。Lid Radix Salviae Miltiorrhizae can break stagnated blood, mends fresh blood, peaceful tire, and fall stillborn fetus, only metrorrhagia dysentery, regulating menstruation arteries and veins。Main Compositions of Radix Salviae Miltiorrhizae TANSHINONES has expansion blood vessel, improves circulation, releases the effects such as intravascular coagulation, has effect of invigorating blood circulation trace, and can promote that liver blood circulates, is beneficial to liver cell regeneration。
Scorpio, edible, medicinal history is long。The primary medicinal component of Scorpio is charybdotoxin, and according to Compendium of Material Medica and " Chinese Pharmacopoeia " load, Scorpio has " spasmolytic that relieves dizziness, high fever, infantile convulsions, epilepsy, etc., antiinflammatory counteracting toxic substances, removing obstruction in the collateral to relieve pain " function;Cure mainly diseases such as " infantile convulsion, tic spasm, dermatosis, cardiovascular and cerebrovascular disease, inflammation, hepatitis B, tumors "。Scorpio is also a kind of high-grade delicious food, nutritious, the preventing and curing diseases of food, enhancing immunity and anti-ageing function of waiting for a long time。
Squama Manis, part of being used as medicine, the scute of Squama Manis, effect and effect: blood circulation promoting and dispersing pathogen accumulation;Stimulate the menstrual flow stimulating milk secretion;Eliminating carbuncle is burst hard。Main blood stasis amenorrhea;Lump in the abdomen;Rheumatic arthralgia;Agalactia;Carbuncle;Scrofula。For amenorrhea abdominal mass, galactostasis, carbuncle sore tumefacting virus, arthralgia, numbness contracture。
Radix Achyranthis Bidentatae: bitter in the mouth, acid;Property is put down, and returns liver;Kidney channel, has invigorating the liver and kidney;Bone and muscle strengthening;Promoting blood circulation to restore menstrual flow;Ignite (blood) descending;Effect of inducing diuresis for treating stranguria syndrome, cures mainly soreness of waist and knee joint;Flaccidity and weakness of the lower limbs;Amenorrhea due to stagnation of blood;Dysmenorrhea;Puerperal abdominal pain due to blood stasis;Lump in the abdomen;Retention of placenta;Pyretic stranguria;Stranguria with blood;Traumatic injury;Carbuncle malignant boil;Laryngopharynx swelling and pain etc. are demonstrate,proved。
Rhizoma Et Radix Notopterygii, acrid in the mouth;Bitter;Warm in nature。Dissipate exterior cold;Wind-damp dispelling;Profit joint;Pain relieving。Main affection of exogenous wind-cold;Have a headache lossless;Edema due to wind pathogen edema;Sore swollen toxin。For impotence and seminal emission, enuresis frequent micturition, chills and pain of the waist and kness, suffer from a deficiency of the kidney and breathe heavily, Diarrhoea;External curing vitiligo, alopecia areata。Induce sweat cold expelling, expelling wind and dampness, pain relieving。
Rhizoma Atractylodis Macrocephalae bitter in the mouth, sweet, temperature。Return spleen, stomach warp。Cure mainly invigorating the spleen and benefiting QI, dampness diuretic, hidroschesis, antiabortive。For insufficiency of the spleen lack of appetite, abdominal distention is had loose bowels, phlegm retention vertigo and palpitation, edema, spontaneous perspiration, frequent fetal movement。Oncocyte is had cytotoxicity by the Rhizoma Atractylodis Macrocephalae, can reduce the rate of increase of oncocyte, lowers the aggressive of tumor tissue, improves the ability of body antitumor reaction。Mice ehrlich carcinoma, lymphosarcoma ascitic type, the esophageal carcinoma (Ecal09), sarcoma 180 etc. are had inhibitory action by Rhizoma Atractylodis Macrocephalae volatile oil。Atractylodes lactone B lumbar injection is to the murine sarcoma people。Also effect is significantly inhibited。" property of medicine opinion " carries it: monarch, and sweet in the mouth is pungent, nontoxic。The main big migratory arthralgia of energy, diarrhea due to disorder of qi for many years, trusted subordinate's distending pain, the broken dyspepsia that disappears, appetizing, remove sputum, except cold and heat, let out under only。Interarea light is pleased, and preserves youthful looks, de-black。Swelling of harnessing the river is full, tells vomiting, cold type of pain in abdomen, vomits and diarrhoea incessantly, and insufficiency of stomach-QI cold-dysentery。
Fructus Atriplicis Sibiricae is that annual or herbaceos perennial Fructus Tribuli TribulusterrestrisL the mature fruit of zygophyllaceae is bitter, pungent, flat, enters Liver Channel。Suppressing the hyperactive liver resolving depression, dispelling pathogenic wind for improving eyesight。Have a headache for dizziness due to hyperactivity of liver-YANG, hypochondriac pain due to stagnation of liverQI, headache due to pathogenic wind-heat, conjunctival congestion and swelling pain, the disease such as skin pruritus。
Radix Notoginseng: the sweet mildly bitter flavor of Radix Notoginseng property, warm in nature, return liver, stomach through being used as medicine with root, root stock。Rare Chinese medicine, raw with can hemostasia and dissipation blood stasis, reducing swelling and alleviating pain, there is good hemostasia effect, significant hemopoietic function;Tightening and improving Coronary microcirculation, Radix Notoginseng is used as medicine with a long history, acts on the peculiar treasured being considered as in medicine by ancient Chinese medicine doctor, therefore has the saying of " Radix Stephaniae Sinicae (Radix Stephaniae Dielsianae) "。" taste is micro-sweet and bitter, quite like the taste of Radix Ginseng for Radix Notoginseng。" " all canes flutter trauma, the dripping person of blood stasis, chew namely stopping of rotten net for catching birds or fish immediately, and namely bruise person dissipate。If during by cane, first taking one, two money, then the blood not centre of punch, especially should taking it after cane, puerperal, clothes were also good。On the whole this medicine temperature, sweet and slightly bitter taste, and sun is bright, the medicine of cloudy blood system of fainting, therefore all disorders of blood can be controlled "。" book on Chinese herbal medicine is looked for the truth " is recorded: " Radix Notoginseng, common people only know function hemostasis and pain-relieving。Hardly realizing that pain aches work because of blood stasis, because of deposited dissipating, blood stops blood。Radix Notoginseng abnormal smells from the patient hardship temperature, can in its blood stasis of blood systemization。" Radix Notoginseng can increase coronary flow, decreased heart rate, reduce myocardial oxygen consumption, increase cardiac muscle oxygen-resistant ability, improve microcirculation, release the effect of smooth muscle spasm。
Herba Artemisiae Scopariae: bitter in the mouth, pungent, cold nature。Return spleen, stomach, liver, gallbladder meridian。Function cures mainly: clearing away damp-heat, jaundice eliminating subcutaneous ulcer。For jaundice oliguria, eczema pruritus;Infectious jaundice type hepatitis。" herbal classic ": the raw pathogenic heat gas of main air, accumulation of heat jaundice。" not Lu ": control the whole body jaundice, dysuria, except feverish sensation in the head, remove mass in the large intestine。Supplement to the Herbal: get round by bribery, goes stagnant heat, and typhoid fever uses it。" medical center bun is wanted ": hard kidney, dry spleen wets, and goes strongly fragrant, antipyretic。" book on Chinese herbal medicine is new again ": pathogenic fire purging, suppressing the hyperactive liver, reduces phlegm, cough-relieving diaphoresis, dampness removing, detumescence, treats the skin ulcer all poison of fire。
Cortex Mori is the root bark of moraceae plants Mulberry MorusalbaL.。Main product in Anhui, Henan, Zhejiang, Jiangsu, the ground such as Hunan。Effect: eliminating pathogen from the lung for relieving asthma, inducing diuresis to remove edema。For diseases such as lung-heat cough with asthma, the edema of the face, dysuria。" property of medicine opinion ": make, flat。Controlling lung qi dyspnea with fullness of the chest, aqueous vapor edema, main wound is exhausted, dredging water passages, and disappear aqueous vapor, and asthenia exopathogenic heat is had a headache, interior tonifying for the deficiency。" Japan hanako materia medica ": temperature, in tune, the therapeutic method to keep the adverse QI flowing downwards。Expectorant is quenched the thirst, profit intestine and small intestine, appetizing, and lower food kills abdomen and hides worm, and only cholera is vomited and diarrhoea。
Caulis Spatholobi, property is bitter, sweet, temperature。Return liver, kidney channel, enrich blood, invigorate blood circulation, dredging collateral。For menoxenia, blood deficiency and yellow complexion, paralysis and numbness, rheumatic arthralgia relaxing muscles and tendons to promote blood circulation;Nourishing blood for regulating menstruation, supplementary Amplifications of the Compendium of Materia Medica carries it can cure numb hand and foot;Quadriplegia;Rheumatic arthralgia;Women has through uncomfortable;Dysmenorrhea。External is gynecological's good medicine of activating blood circulation to dissipate blood stasis。
Ramulus Uncariae Cum Uncis, sweet in the mouth, cool in nature。Enter liver, heart channel。Energy heat clearing away suppressing the hyperactive liver, relieve dizziness, high fever, infantile convulsions, epilepsy, etc. arresting convulsion。Cure mainly pediatric epilepsy scared, adult's slight Hypertension, dizzy, dizzy, married woman's eclamposia。Its pharmacological action has sedation and hypotensive effect。
Flos Carthami is warm in nature, acrid in the mouth。Function cures mainly and is applied to invigorate blood circulation latus rectum, eliminating stasis to stop pain。For amenorrhea, dysmenorrhea, lochia, lump in the abdomen mass in the abdomen, traumatic injury。" book on Chinese herbal medicine converge with speech ": Flos Carthami, removing blood stasis, promoting the circulation of blood and blood, tune blood medicine also。Main tire produces all kinds of diseases and ailments because blood is for suffering from, or the tired bruise of blood, and coma is in silence;Or lochia robs the heart, umbilicus angina abdominis;Or drop slurry difficulty is raw,;Or afterbirth does not fall, dead fetus in the uterus, is all just before giving birth all cards, and non-Flos Carthami can not be controlled。If puerperal blood faints, locked mouth refer to hold in the hand;Or heresy enters blood room, delirium is gone mad;Or blood is vexed interior swollen, sudden syncope with rigidity as extremely, is all cards in puerperal, and non-Flos Carthami can not be determined。All as obstructed in amenorrhea and cold and heat are handed over and are made, or expired stomachache and purple black dripping, or injury from falling down and the QI and blood stasis of blood amass, or skin infection sufferings and swollen uneasiness of bursting, it is the card of all disharmony between QI and blood, non-Flos Carthami can not be adjusted, Flos Carthami promoting blood circulation to restore menstrual flow, reducing swelling and alleviating pain, there are inhibition thrombosis, antiinflammatory, analgesic effect, there is the vasoconstrictive effect eliminating epinephrine, norepinephrine, have " tonneau passages through which vital energy circulates " to act on。
Folium Crossostephii Chinensis: high and cold Folium Crossostephii Chinensis and coreopsis tinctoria have rubbish in efficient blood fat reducing, vessel softening, removing body; reach the body fluid balance of human body, improve painstaking effort output, increase myocardial oxygen delivery amount; coronary heart disease, hyperlipidemia, diabetes are had special curative effect by the normal physiological function of protection ischemic myocardium。
Poria sweet in the mouth, light, property are put down, and are used as medicine and have the function of promoting diuresis to eliminate damp pathogen, strengthening the spleen stomach function regulating, mind tranquilizing and the heart calming。Modern medicine study: Poria energy enhancing human body immunity function, pachyman has obvious antitumor and protects the liver dirty effect。Poria slightly sweet flavor is put down, and enters the heart, lung, spleen channel。There is eliminating dampness and diuresis, invigorating the spleen and regulating the stomach, effect of mind tranquilizing and the heart calming。Dysuria, edema distension, phlegm retention cough with dyspnea, vomiting, malignant histocytosis can be controlled, have loose bowels, seminal emission, stranguria with turbid discharge, palpitation with fear, forgetful disease such as grade。The diuretic of Poria, is reached by strong activating the spleen pulmonary function, different from the Chinese medicine of other direct diuretic。For diarrhea due to hypofunction of the spleen, leukorrhagia Poria can spleen invigorating, again can eliminating dampness by diuresis, for having loose bowels caused by insufficiency of the spleen dysfunction of the spleen in transportation and transformation, leukorrhagia, application Poria has the effect of giving consideration to both the incidental and fundamental, often and the compatibility such as Radix Codonopsis, the Rhizoma Atractylodis Macrocephalae, Rhizoma Dioscoreae。Can be used as tonifying the lung spleen, control the adjuvant of the deficiency of vital energy。
Herba Saussureae Involueratae: Herba Saussureae Involueratae has physiologically active effective ingredient。Wherein umbelliferone have significantly antibacterial, blood pressure lowering is calm, spasmolysis;Have and dispel the wind, antiinflammatory, pain relieving, eliminate the phlegm and antitumor action, can the growth of anticancer, clinical have certain curative effect with breast carcinoma especially in order to treat cancer, and skin carcinoma, leukemia and what king's evil etc. are also had certain effect。To the special effect of gout acute attack。
Folium Eucommiae is the dried leaves of Eucommiaceae plant Cortex Eucommiae EucommiaulmoidesOliv.。Summer, season in autumn two branch and leaf luxuriant time gather, dry or oven drying at low temperature。Micro-pungent, temperature。Return liver, kidney channel。Function with cure mainly: invigorating the liver and kidney, bone and muscle strengthening。For deficiency of the liver and kindey, having a dizzy spell, soreness of waist and knee joint, muscles and bones flaccidity is soft。Effect to cardiovascular system, is significantly increased the effect of coronary flow to action of the heart Folium Eucommiae water decoction-alcohol sedimentation liquid 0.2g to guinea pig isolated heart tool。Rabbit intravenous 20g/kg, the ST section that intravenous isoproterenol is caused is raised and the change of T ripple does not have antagonism。After hypotensive effect anesthetized dog and cat intravenous Folium Eucommiae water decoction 0.4g/kg, blood pressure declines rapidly, namely gos up gradually after maintaining 5 minutes;During the above dosage of intravenous 1g/kg, blood pressure is remarkably decreased, and can maintain the long period。Alcohol extract also has a hypotensive effect, but Amplitude of Hypotensive and hold time all poor than water decoction。The drop test of anesthetized dog and cat all proves, Folium Eucommiae water decoction and alcohol extract repeat Bolos intravenous administration in a short time can produce tachylaxis, and successive administration pressure reduction effect even can not occur 3-4 time。Water decoction and the 65% ethanol extract 6g/kg intravenous of Folium Eucommiae all can cause rabbits blood pressure to be decreased obviously。The aqueous solution of Folium Eucommiae, alcoholic solution, ethereal solution and each composition such as saccharide, alkaloid of process purification, aucubin, chlorogenic acid, to rabbit intravenous, all have hypotensive effect in various degree。
Radix Angelicae Sinensis, its sweet in the mouth and weigh, therefore specially can enrich blood, its gas is light and pungent, therefore again can promoting the circulation of blood, invigorating middle warmer has, has benefit in row, the gas medicine in sincere blood, the also panacea in blood。Then mending to mend of about assistant, therefore nutrition blood can be supported, QI invigorating spermatogenesis, settling five organs, strong body, benefit mind, all tangible deficient diseases, unsuitable without institute。Assistant to attack, lead to, therefore pain relieving constipation of dispelling, relieving rigidity of muscles and joints, control contracture, paralysis, the card such as dry, puckery。Nutrient QI being deficient and exterior syndrome being not relieved person, assistant, with agent such as bavin, Pueraria lobota, fiber crops, osmanthus, can dissipate greatly Biao Weire, and person do not held back by table, help with Radix Et Rhizoma Rhei etc, again can consolidating superficial resistance。Precisely because gas Xin Erdong, therefore it is intended to its quiet person when keeping away it, the sliding benefaction of property, stool does not consolidate person when keeping away it。All cloudy moderate heat Sheng persons, the active blood of Radix Angelicae Sinensis, also non-institute is suitable, and cloudy deficiency of YANG of middle-JIAO person, Radix Angelicae Sinensis can nourish blood, and is indispensable。
Rhizoma Chuanxiong, pungent, temperature。Enter liver, gallbladder meridian。Activating QI to alleviate the depression, method wind-dryness is wet, promoting blood circulation and stopping pain。Controlling air-cooled headache rotation dizzy, hypochondriac pain abdomen aches, arthralgia due to cold clonic spasm of the muscle, amenorrhea, difficult labour, postpartum stagnation block pain, ulcer sores。For menoxenia, amenorrhea dysmenorrhea, abdominal mass is suffered from abdominal pain, breast side of body twinge, tumbling and swelling, headache, rheumatic arthralgia。" herbal classic " carries it: main apoplexy enters brain headache, arthralgia due to cold, clonic spasm of the muscle emergency, and gold wound, married woman's blood closes loss of fecundity。" not Lu " carries it: " except cold dynamic in brain, on face, urticaria goes, order lacrimation, profuse nasal discharge and spittle, before we notice it as liquor-saturated, all cold gas, trusted subordinate's heavily fortified point pain, attacked by pestiferous factors, soldier is anxious to swell and ache, side of body wind bitterly, warming middle-JIAO endogenous cold。" it is the good medicine of regulating qi to disperse stagnation。
Pericarpium Citri Reticulatae is warm in nature, acrid in the mouth, bitter in the mouth。Enter spleen channel, stomach warp, lung meridian。Regulating qi-flowing for strengthening spleen, in tune, dampness, reduce phlegm。Cure mainly distension and fullness in the abdomen or pain, the dyspepsia of stagnation of QI in spleen and stomach。Abdominal distention uncomfortable in chest in turbid damp resistance, indigestion and loss of appetite loose stool。Phlegm-damp stops up the cough and asthma of lung。For fullness in the epigastrium and chest, lack of appetite and vomiting, cough with copious phlegm。Compendium of Material Medica: it is to hundred and always takes chess and regulates the flow of vital energy the merit of dampness, then mends with tonic, then rushes down with cathartic, then rise with Hydrargyri Oxydum Rubrum, then drops with dropping medicine。Spleen is the mother of vigour, lung be take the photograph gas want, therefore Pericarpium Citri tangerinae be two through edema caused by disorder of QI want, but with join and reinforcing and reducing lift also。" daily book on Chinese herbal medicine ": can dissipate and can rush down, can temperature can mend, and can disappear diaphragm gas, and reduce phlegm saliva, and spleen antitussive, logical five types of stranguria。
The micro-hardship of Rhizoma Polygoni Cuspidati, it is slightly cold。Return liver, gallbladder, lung meridian。There is the function of heat-clearing and toxic substances removing, promoting the function of the gallbladder to alleviate jaundice, expelling wind and removing dampness, dissipating blood stasis analgesic therapy, relieving cough and resolving phlegm。Cure mainly arthralgia, jaundice due to damp-heat, amenorrhea, abdominal mass, cough with copious phlegm, burn due to hot liquid or fire, injury from falling down, carbuncle sore tumefacting virus。Anemia of pregnant woman is cautious use of。
Pheretima: salty in the mouth is cold in nature, returns liver, spleen, bladder warp, clearing away heat and relieving the wind syndrome, dredging collateral, diuresis of relievining asthma。Modern pharmacological research Pheretima has the effects such as analgesia, convulsion, antipyretic, blood pressure lowering, antithrombotic, antitumor。
Herba Portulacae inducing diuresis to remove edema, reduces blood pressure。Herba Portulacae contains substantial amounts of potassium salt, has good inducing diuresis to remove edema effect;Potassium ion also can be done directly in blood vessel wall, makes blood vessel wall expand, and stops ductus arteriosus wall to thicken, thus playing the effect reduced blood pressure。Medicinal function is heat-clearing and toxic substances removing, cooling blood for hemostasis。Because it contains abundant norepinephrine, pancreas islet gland excreting insulin can be promoted, regulate human body carbohydrate metabolism process, reduce blood sugar concentration, keep blood glucose constant, so diabetes have certain therapeutical effect。In addition it contains a kind of unsaturated fatty acid being called 3 W, the generation of cholesterol and triglyceride can be suppressed, cardiovascular is had protective effect。Compendium of Material Medica: " dissipate blood detumescence, profit intestinal habitual abortion, detoxify treating stranguria, sweating due to debility after managing property。"
Folium Ginkgo: function cures mainly: relieving asthma, blood circulation promoting and blood stasis dispelling, pain relieving, for cough and asthma due to lung deficiency, coronary heart diseases and angina pectoris, hyperlipidemia。
Radix Puerariae, sweet in the mouth, pungent, cool in nature。Enter spleen, stomach warp。There is yang invigorating expelling pathogenic factors from muscles, rash antidiarrheal, effect of relieving restlessness only temperature。For typhoid fever, warm headache stiffness of the nape, dysphoria with smothery sensation is quenched one's thirst, and has loose bowels, dysentery, and skin eruption is not saturating, hypertension, and angina pectoris is deaf。It is used for Hypertension neck pain, angina pectoris clinically, but also there is hypoglycemic activity。
Semen Cassiae is the mature seed of leguminous plant Semen Cassiae, is also known as Semen Cassiae。Shennong's Herbal is recorded Semen Cassiae sweetness and bitterness and is slightly cold, and returns liver, gallbladder, kidney three warp, has liver heat removing and eyesight improving, loosening bowel to relieve constipation, the function of lipid-lowering weight-reducing, can be used for dizziness of having a headache, and conjunctival congestion is dim-sighted, constipation etc., in recent years clinically again for the treatment of hypertension。Semen Cassiae, containing anthraglycosides material, produces rheum emodin, physcione, chrysophanic acid, chrysophanol and glucose etc. after decomposition。It is demonstrated experimentally that Semen Cassiae has blood pressure lowering, blood fat reducing, the effect such as antibacterial, being used for treating hyperlipemia has certain curative effect。Except medicinal ingredient, Semen Cassiae is possibly together with multivitamin and abundant aminoacid, carbohydrate etc.。
Fructus Crataegi: property, tepor。Taste is sweet, sour。Enter spleen, stomach, Liver Channel。This product is apt to promoting QI to circulate and dispersing the agglomeration of the pathogens, the effect of promoting digestion and removing stagnation;Current QI and blood, blood circulation promoting and blood stasis dispelling, treatment hyperlipidemia, hypertension all have good therapeutic effect;Its energy blood fat reducing, atherosclerosis, can reduce again serum cholesterol and triglyceride;Can also coronary artery dilator, increase coronary flow, Ischemic myocardium anoxia, heart tonifying, blood pressure lowering and arrhythmia;Removing Blood Stasis and do not hinder fresh blood, dissipating depression of QI gas and do not hinder healthy energy, its property peace especially is also。
Rhizoma Gastrodiae: property is flat。Taste, sweet。Master enters Liver Channel。This product endogenous wind stopping relieving convulsion, suppressing liver-YANG, dispelling wind and removing obstruction in the collateral。For controlling the key medicine of dizziness, headache;Again in numb limbs and tense tendons, hands and feet caused by paralysis, rheumatic arthralgia, the good merchantable brand of muscles and bones contracture。
Theory of Chinese medical science is thought, " three high " disease disease mainly by the imbalance of YIN and YANG of the heart, Liver and kidney function, adds that exopathogen such as experiencing wind, heat, poison is attacked, and the expectorant in human body, the mutual knot of the stasis of blood, and caused by various factors interacts。Therefore, by suppressing the hyperactive liver and subsiding YANG, vital energy regualting and blood circulation-promoting, YIN nourishing supports kidney, and Qingre Quyu is the effective way that treatment " three high " disease is sick。Desirable medicine should be to reverse its pathological process vessel softening while, prevents and treats the generation of complication, and should without obvious toxic and side effects。The present invention is based on above-mentioned theory, collects multiple Chinese herbal medicine and develops。Its present invention can quick blood circulation promoting and blood stasis dispelling, dredge the meridian passage, for hyperlipidemia, drop that blood is viscous, vessel softening, adjustment blood fat, for treating and preventing " three high ", there is unique curative effect。
The pharmaceutical composition compatibility of the vessel softening of the present invention meets Chinese medicine " monarch " principle, gives prominence to the key points, comprehensive and reasonable, by oral drugs scalable function, reduce blood fat, vessel softening, make blood matter rare clearly, increase blood flowing vigor, softening vessel effect is obvious, and abundant raw materials, preparation technology is simple, has no side effect, price is low, has good application prospect in vessel softening, treatment and prevention " three high " especially hyperlipidemia。
Detailed description of the invention
For making the purpose of the embodiment of the present invention, technical scheme and advantage clearly, below in conjunction with embodiment, technical scheme is clearly and completely described。Obviously, described embodiment is the part of the present invention, rather than whole embodiments。Based on described embodiments of the invention, the every other embodiment that those of ordinary skill in the art obtain under the premise without creative work, broadly fall into the scope of protection of the invention。Except as otherwise noted, the percent of the amount of alcohol in the present invention is percentage by volume, and v/v represents the volume ratio of solution。
Embodiment 1:
The pharmaceutical composition of a kind of vessel softening of the present invention, takes following traditional Chinese medicine raw medicine: 12 grams of crataegus pin natifida var. Major leaf, Scorpio 16 grams, Radix Angelicae Sinensis 3 grams, Squama Manis 12 grams, Radix Achyranthis Bidentatae 12 grams, Radix Salviae Miltiorrhizae 10 grams, 9 grams of Flos Carthami, the Rhizoma Atractylodis Macrocephalae 15 grams, Fructus Atriplicis Sibiricae 15 grams, Herba Artemisiae Scopariae 8 grams, Cortex Mori 5 grams, Rhizoma Et Radix Notopterygii 3 grams, Caulis Spatholobi 14 grams, Ramulus Uncariae Cum Uncis 9 grams, Rhizoma Chuanxiong 6 grams, Folium Crossostephii Chinensis 8 grams, Herba Saussureae Involueratae 5 grams, Folium Eucommiae 1 gram, Pericarpium Citri Reticulatae 10 grams, Radix Notoginseng 5 grams, Rhizoma Polygoni Cuspidati 16 grams, Pheretima 10 grams, Herba Portulacae 8 grams, Folium Ginkgo 5 grams, 1 gram of Poria, Radix Puerariae 10 grams, Semen Cassiae 6 grams, Fructus Crataegi 8 grams, 3 grams of Rhizoma Gastrodiae。
Embodiment 2:
The pharmaceutical composition of a kind of vessel softening of the present invention, takes following traditional Chinese medicine raw medicine: 20 grams of crataegus pin natifida var. Major leaf, Scorpio 10 grams, Radix Angelicae Sinensis 8 grams, Squama Manis 5 grams, Radix Achyranthis Bidentatae 17 grams, Radix Salviae Miltiorrhizae 12 grams, 4 grams of Flos Carthami, the Rhizoma Atractylodis Macrocephalae 20 grams, Fructus Atriplicis Sibiricae 10 grams, Herba Artemisiae Scopariae 12 grams, Cortex Mori 2 grams, Rhizoma Et Radix Notopterygii 7 grams, Caulis Spatholobi 11 grams, Ramulus Uncariae Cum Uncis 15 grams, Rhizoma Chuanxiong 3 grams, Folium Crossostephii Chinensis 13 grams, Herba Saussureae Involueratae 3 grams, Folium Eucommiae 3 grams, Pericarpium Citri Reticulatae 5 grams, Radix Notoginseng 10 grams, Rhizoma Polygoni Cuspidati 13 grams, Pheretima 3 grams, Herba Portulacae 13 grams, Folium Ginkgo 3 grams, 3 grams of Poria, Radix Puerariae 5 grams, Semen Cassiae 4 grams, Fructus Crataegi 10 grams, 4 grams of Rhizoma Gastrodiae。
Embodiment 3:
The pharmaceutical composition of a kind of vessel softening of the present invention, takes following traditional Chinese medicine raw medicine: 13 grams of crataegus pin natifida var. Major leaf, Scorpio 11 grams, Radix Angelicae Sinensis 4 grams, Squama Manis 6 grams, Radix Achyranthis Bidentatae 13 grams, Radix Salviae Miltiorrhizae 7 grams, 5 grams of Flos Carthami, the Rhizoma Atractylodis Macrocephalae 18 grams, Fructus Atriplicis Sibiricae 11 grams, Herba Artemisiae Scopariae 9 grams, Cortex Mori 4 grams, Rhizoma Et Radix Notopterygii 6 grams, Caulis Spatholobi 12 grams, Ramulus Uncariae Cum Uncis 13 grams, Rhizoma Chuanxiong 4 grams, Folium Crossostephii Chinensis 9 grams, Herba Saussureae Involueratae 4 grams, Folium Eucommiae 2 grams, Pericarpium Citri Reticulatae 6 grams, Radix Notoginseng 6 grams, Rhizoma Polygoni Cuspidati 14 grams, Pheretima 5 grams, Herba Portulacae 10 grams, Folium Ginkgo 4 grams, 2 grams of Poria, Radix Puerariae 6 grams, Semen Cassiae 5 grams, Fructus Crataegi 12 grams, 3 grams of Rhizoma Gastrodiae。
Embodiment 4:
The pharmaceutical composition of a kind of vessel softening of the present invention, takes following traditional Chinese medicine raw medicine: 17 grams of crataegus pin natifida var. Major leaf, Scorpio 15 grams, Radix Angelicae Sinensis 7 grams, Squama Manis 11 grams, Radix Achyranthis Bidentatae 16 grams, Radix Salviae Miltiorrhizae 8 grams, 8 grams of Flos Carthami, the Rhizoma Atractylodis Macrocephalae 16 grams, Fructus Atriplicis Sibiricae 14 grams, Herba Artemisiae Scopariae 11 grams, Cortex Mori 3 grams, Rhizoma Et Radix Notopterygii 5 grams, Caulis Spatholobi 13 grams, Ramulus Uncariae Cum Uncis 14 grams, Rhizoma Chuanxiong 5 grams, Folium Crossostephii Chinensis 12 grams, Herba Saussureae Involueratae 3 grams, Folium Eucommiae 1 gram, Pericarpium Citri Reticulatae 10 grams, Radix Notoginseng 9 grams, Rhizoma Polygoni Cuspidati 13 grams, Pheretima 7 grams, Herba Portulacae 11 grams, Folium Ginkgo 3 grams, 1 gram of Poria, Radix Puerariae 10 grams, Semen Cassiae 4 grams, Fructus Crataegi 11 grams, 4 grams of Rhizoma Gastrodiae。
Embodiment 5:
The pharmaceutical composition of a kind of vessel softening of the present invention, takes following traditional Chinese medicine raw medicine: 15 grams of crataegus pin natifida var. Major leaf, Scorpio 12 grams, Radix Angelicae Sinensis 5 grams, Squama Manis 9 grams, Radix Achyranthis Bidentatae 15 grams, Radix Salviae Miltiorrhizae 9 grams, 7 grams of Flos Carthami, the Rhizoma Atractylodis Macrocephalae 19 grams, Fructus Atriplicis Sibiricae 13 grams, Herba Artemisiae Scopariae 10 grams, Cortex Mori 4 grams, Rhizoma Et Radix Notopterygii 4 grams, Caulis Spatholobi 11 grams, Ramulus Uncariae Cum Uncis 11 grams, Rhizoma Chuanxiong 5 grams, Folium Crossostephii Chinensis 10 grams, Herba Saussureae Involueratae 5 grams, Folium Eucommiae 3 grams, Pericarpium Citri Reticulatae 8 grams, Radix Notoginseng 8 grams, Rhizoma Polygoni Cuspidati 14 grams, Pheretima 9 grams, Herba Portulacae 12 grams, Folium Ginkgo 5 grams, 3 grams of Poria, Radix Puerariae 8 grams, Semen Cassiae 6 grams, Fructus Crataegi 9 grams, 5 grams of Rhizoma Gastrodiae。
Embodiment 6:
The pharmaceutical composition of a kind of vessel softening of the present invention, takes following traditional Chinese medicine raw medicine: 19 grams of crataegus pin natifida var. Major leaf, Scorpio 14 grams, Radix Angelicae Sinensis 6 grams, Squama Manis 7 grams, Radix Achyranthis Bidentatae 14 grams, Radix Salviae Miltiorrhizae 9 grams, 6 grams of Flos Carthami, the Rhizoma Atractylodis Macrocephalae 17 grams, Fructus Atriplicis Sibiricae 13 grams, Herba Artemisiae Scopariae 10 grams, Cortex Mori 4 grams, Rhizoma Et Radix Notopterygii 4 grams, Caulis Spatholobi 11 grams, Ramulus Uncariae Cum Uncis 11 grams, Rhizoma Chuanxiong 5 grams, Folium Crossostephii Chinensis 10 grams, Herba Saussureae Involueratae 5 grams, Folium Eucommiae 3 grams, Pericarpium Citri Reticulatae 8 grams, Radix Notoginseng 8 grams, Rhizoma Polygoni Cuspidati 14 grams, Pheretima 4 grams, Herba Portulacae 9 grams, Folium Ginkgo 5 grams, 3 grams of Poria, Radix Puerariae 8 grams, Semen Cassiae 3 grams, Fructus Crataegi 8 grams, 5 grams of Rhizoma Gastrodiae。
Wherein, the preparation method of the described Chinese medicine composition of embodiment 1-6 is:
(1) each medical material of components by weight percent in the arbitrary described Chinese medicine composition of Example 1-6, add in the ethanol of 5-10 times amount and soak 1-2 hour, heating extraction 2 times, each 1-2 hour, removes supernatant, united extraction liquid, 100-120 order filters, the ultrafiltration post ultrafiltration that molecular weight is 5000-10000 then through damming, the extractum of 1.36 when ultrafiltrate concentrating under reduced pressure relative density is 80 DEG C, heating is concentrated into paste, stand for standby use;
(2) being put in 10 times amount water by the medicinal residues that ethanol extraction is crossed, be then placed in extraction pot heated and boiled 1 hour, filter, filtrate is standby;Filtering residue adds water, second time heating, boils 45 minutes, filters, and filtrate is standby;
(3) 2 filtrates in step (2) being combined, by filtered through gauze, add 50-60% ethanol in residue, 60 DEG C-70 DEG C are continued lixiviate 2h, every 10min and stir once, and filtered through gauze merges lixiviating solution, is condensed into pasty state;
(4) the pastel decompression recycling ethanol that step (1) paste that obtains of concentration and step (3) obtained to be concentrated into liquor strength be 0.6-0.7g crude drug/mL, after sucking filtration, the relative density of filtrate is about 1.0-1.1 when 20 DEG C;It is centrifuged under the rotating speed of 3000r/min;At 60 DEG C of-80 DEG C of spray drying, obtain dry extract;
(5) dry extract that step (4) prepares is pulverized, add suitable amount of sucrose, dextrin mixing, with ethanol for wetting agent, granulate, dry, granulate, granule can be prepared;Or the dry extract that step (4) prepares be dry, pulverize, make powder;Or dry extract step (4) prepared is pulverized, add appropriate micropowder silica gel, α-galactose mixing, with ethanol for wetting agent, granulate, dry, granulate, encapsulated, prepare capsule;Or dry extract step (4) prepared is pulverized, add suitable amount of sucrose, dextrin mixing, with ethanol for wetting agent, granulate, dry, granulate, tabletting, prepare tablet;Or to above-mentioned steps (4) obtain centrifugal after concentrated solution in add suitable amount of sucrose, essence mixing, sterilizing, fill, prepare medicinal liquid agent。
Acute toxicity test
Method one:
Test material: Kunming mouse 40, body weight 22-25g。Medicine: the medicinal liquid agent that the embodiment of the present invention 3 prepares, containing 0.0365mg/ml。
Method:
LD50 calculates: adopt improvement karber's method, mice is randomly divided into 4 groups, often group 10, the medicinal liquid agent that the embodiment of the present invention 3 prepares is added distilled water dissolve, be made into Cmax, by the maximum allowable capacity administration of mice, institute is followed successively by 18,14.4,11.5 to dosage by crude drug amount, 9.2,7.4 (g.kg-1), after animal fasting (can't help water) 18 hours, administration (interval half an hour) at twice in a day, each 0.5ml, observes animal dead situation。
Result of the test: in LD50 calculates when giving mice with maximum acceptable concentration and maximum allowable capacity (18g/Kg.d), have no dead mouse, namely LD50 is not measured, seeking maximum tolerated dose only, to observation post administration 14 days, none was dead for mice, main organs no abnormality seen, also have no other substantially abnormal, within the 14th day, put to death and cut open inspection some animals, perusal main organs no abnormality seen。Namely select the 300 times of doses being equivalent to clinical dosage, and have no adverse reaction, it was shown that acute toxicity is minimum, MTD > 18g/Kg.d。
Six months long term toxicity tests: weigh weekly once during administration, claim appetite every day, and without dead or moribund animals, result mice hair color is bright and clean, and behavioral activity, glandular secretion, breathing, feces character are all normal。Pathologic finding is pointed out, to various internal organs without obvious drug-induced pathological change。
Clinical reasoning:
In order to verify the effect of pharmaceutical composition of the present invention, in May ,-2014 in October, 2012, hyperlipemic patients 180 example is randomly drawed in outpatient service place, year at age 45~68 (55 ± 10.41), male patient 88 example, female patient 92 example。In hyperlipidemia medical history 3~16 (8.92 ± 3.21) year, body weight, height, motion, diet etc. do not have notable difference, P > 0.05, wherein 1 phase hyperpietic 90 example, 2 phase phase hyperpietic 65 examples, 3 phase hyperpietic 25 examples。It is randomly divided into treatment group and each 90 examples of matched group。
Electrocardiogram and lab testing:
Equal routine examination blood pressure (BP), electrocardiogram (ECG), glycolated hemoglobin (Hbaic%), triglyceride (TG), low density lipoprotein, LDL (LDLC), high density lipoprotein fHDL after being admitted to hospital) etc.。
Treatment
Matched group carries out conventional therapy, adopts the routine medication such as XINKESHU PIAN, JIANGZHILINGPIAN, actively moves。
Treatment group uses the tablet of embodiment 3 to treat, each two panels, every day 2-3 time, 10 days courses for the treatment of, continuously 2-4 the course for the treatment of of treatment, does not increase the Therapeutic Method of other traditional Chinese medical science or doctor trained in Western medicine。
Curative effect determinate standard
Cure: symptom all disappears;Main Physico-chemical tests index is normally。
Effective: symptomatology eliminates or cardinal symptom eliminates;Physico-chemical tests index is normal。
Effective: cardinal symptom disappears substantially;Main Physico-chemical tests index makes moderate progress。
Invalid: main Physico-chemical tests index is front with treatment unchanged。
Result:
Curative effect comparision result such as following table after two groups of case treatments:
Two groups of patient clinical comparitive study (example %)
Group | Number of cases | Cure | Effective | Effectively | Invalid | Total effective |
Treatment group | 90 | 27 (30%) | 54 (60%) | 6 (6.7%) | 3 (3.3%) | 87 (96.7%) |
Matched group | 90 | 4 (4.4%) | 27 (30%) | 11 (12.2%) | 48 (53.3%) | 42 (46.7%) |
Two groups of patient clinical comparitive study: treatment group total effective rate is 96.7%, matched group is 46.7%, two groups of comparing differences statistically significant (P < 0.05)。Treatment group is better than matched group。Visible, medicine that the preferred embodiment for the present invention prepares can safe and effective vessel softening, effective percentage is significantly higher than matched group。
Last it is noted that above example is only in order to illustrate technical scheme, it is not intended to limit;Although the present invention being described in detail with reference to previous embodiment, it will be understood by those within the art that: the technical scheme described in foregoing embodiments still can be modified by it, or wherein portion of techniques feature is carried out equivalent replacement;And these amendments or replacement, do not make the essence of appropriate technical solution depart from the scope of various embodiments of the present invention technical scheme。
Claims (10)
1. the pharmaceutical composition of a vessel softening, it is characterised in that: the crude drug of described pharmaceutical composition is made up of crataegus pin natifida var. Major leaf, Radix Salviae Miltiorrhizae, Scorpio, Squama Manis, Radix Achyranthis Bidentatae, Rhizoma Et Radix Notopterygii, the Rhizoma Atractylodis Macrocephalae, Fructus Atriplicis Sibiricae, Radix Notoginseng, Herba Artemisiae Scopariae, Cortex Mori, Caulis Spatholobi, Ramulus Uncariae Cum Uncis, Flos Carthami, Folium Crossostephii Chinensis, Poria, Herba Saussureae Involueratae, Folium Eucommiae, Radix Angelicae Sinensis, Rhizoma Chuanxiong, Pericarpium Citri Reticulatae, Rhizoma Polygoni Cuspidati, Pheretima, Herba Portulacae, Folium Ginkgo, Radix Puerariae, Semen Cassiae, Fructus Crataegi, Rhizoma Gastrodiae。
2. the pharmaceutical composition of vessel softening according to claim 1, it is characterized in that: make described pharmaceutical composition raw material composition and parts by weight be: crataegus pin natifida var. Major leaf 12-20 part, Scorpio 10-16 part, Radix Angelicae Sinensis 3-8 part, Squama Manis 5-12 part, Radix Achyranthis Bidentatae 12-17 part, Radix Salviae Miltiorrhizae 7-12 part, Flos Carthami 4-9 part, Rhizoma Atractylodis Macrocephalae 15-20 part, Fructus Atriplicis Sibiricae 10-15 part, Herba Artemisiae Scopariae 8-12 part, Cortex Mori 2-5 part, Rhizoma Et Radix Notopterygii 3-7 part, Caulis Spatholobi 11-14 part, Ramulus Uncariae Cum Uncis 9-15 part, Rhizoma Chuanxiong 3-6 part, Folium Crossostephii Chinensis 8-13 part, Herba Saussureae Involueratae 3-5 part, Folium Eucommiae 1-3 part, Pericarpium Citri Reticulatae 5-10 part, Radix Notoginseng 5-10 part, Rhizoma Polygoni Cuspidati 13-16 part, Pheretima 3-10 part, Herba Portulacae 8-13 part, Folium Ginkgo 3-5 part, Poria 1-3 part, Radix Puerariae 5-10 part, Semen Cassiae 3-6 part, Fructus Crataegi 8-13 part, Rhizoma Gastrodiae 3-5 part。
3. the pharmaceutical composition of vessel softening according to claim 1, it is characterized in that: make described pharmaceutical composition raw material composition and parts by weight be: 12 parts of crataegus pin natifida var. Major leaf, Scorpio 16 parts, Radix Angelicae Sinensis 3 parts, Squama Manis 12 parts, Radix Achyranthis Bidentatae 12 parts, Radix Salviae Miltiorrhizae 10 parts, 9 parts of Flos Carthami, the Rhizoma Atractylodis Macrocephalae 15 parts, Fructus Atriplicis Sibiricae 15 parts, Herba Artemisiae Scopariae 8 parts, Cortex Mori 5 parts, Rhizoma Et Radix Notopterygii 3 parts, Caulis Spatholobi 14 parts, Ramulus Uncariae Cum Uncis 9 parts, Rhizoma Chuanxiong 6 parts, Folium Crossostephii Chinensis 8 parts, Herba Saussureae Involueratae 5 parts, Folium Eucommiae 1 part, Pericarpium Citri Reticulatae 10 parts, Radix Notoginseng 5 parts, Rhizoma Polygoni Cuspidati 16 parts, Pheretima 10 parts, Herba Portulacae 8 parts, Folium Ginkgo 5 parts, 1 part of Poria, Radix Puerariae 10 parts, Semen Cassiae 6 parts, Fructus Crataegi 8 parts, 3 parts of Rhizoma Gastrodiae。
4. the pharmaceutical composition of vessel softening according to claim 1, it is characterized in that: make described pharmaceutical composition raw material composition and parts by weight be: 20 parts of crataegus pin natifida var. Major leaf, Scorpio 10 parts, Radix Angelicae Sinensis 8 parts, Squama Manis 5 parts, Radix Achyranthis Bidentatae 17 parts, Radix Salviae Miltiorrhizae 12 parts, 4 parts of Flos Carthami, the Rhizoma Atractylodis Macrocephalae 20 parts, Fructus Atriplicis Sibiricae 10 parts, Herba Artemisiae Scopariae 12 parts, Cortex Mori 2 parts, Rhizoma Et Radix Notopterygii 7 parts, Caulis Spatholobi 11 parts, Ramulus Uncariae Cum Uncis 15 parts, Rhizoma Chuanxiong 3 parts, Folium Crossostephii Chinensis 13 parts, Herba Saussureae Involueratae 3 parts, Folium Eucommiae 3 parts, Pericarpium Citri Reticulatae 5 parts, Radix Notoginseng 10 parts, Rhizoma Polygoni Cuspidati 13 parts, Pheretima 3 parts, Herba Portulacae 13 parts, Folium Ginkgo 3 parts, 3 parts of Poria, Radix Puerariae 5 parts, Semen Cassiae 4 parts, Fructus Crataegi 10 parts, 4 parts of Rhizoma Gastrodiae。
5. the pharmaceutical composition of vessel softening according to claim 1, it is characterized in that: make described pharmaceutical composition raw material composition and parts by weight be: 13 parts of crataegus pin natifida var. Major leaf, Scorpio 11 parts, Radix Angelicae Sinensis 4 parts, Squama Manis 6 parts, Radix Achyranthis Bidentatae 13 parts, Radix Salviae Miltiorrhizae 7 parts, 5 parts of Flos Carthami, the Rhizoma Atractylodis Macrocephalae 18 parts, Fructus Atriplicis Sibiricae 11 parts, Herba Artemisiae Scopariae 9 parts, Cortex Mori 4 parts, Rhizoma Et Radix Notopterygii 6 parts, Caulis Spatholobi 12 parts, Ramulus Uncariae Cum Uncis 13 parts, Rhizoma Chuanxiong 4 parts, Folium Crossostephii Chinensis 9 parts, Herba Saussureae Involueratae 4 parts, Folium Eucommiae 2 parts, Pericarpium Citri Reticulatae 6 parts, Radix Notoginseng 6 parts, Rhizoma Polygoni Cuspidati 14 parts, Pheretima 5 parts, Herba Portulacae 10 parts, Folium Ginkgo 4 parts, 2 parts of Poria, Radix Puerariae 6 parts, Semen Cassiae 5 parts, Fructus Crataegi 12 parts, 3 parts of Rhizoma Gastrodiae。
6. the pharmaceutical composition of vessel softening according to claim 1, it is characterized in that: make described pharmaceutical composition raw material composition and parts by weight be: 17 parts of crataegus pin natifida var. Major leaf, Scorpio 15 parts, Radix Angelicae Sinensis 7 parts, Squama Manis 11 parts, Radix Achyranthis Bidentatae 16 parts, Radix Salviae Miltiorrhizae 8 parts, 8 parts of Flos Carthami, the Rhizoma Atractylodis Macrocephalae 16 parts, Fructus Atriplicis Sibiricae 14 parts, Herba Artemisiae Scopariae 11 parts, Cortex Mori 3 parts, Rhizoma Et Radix Notopterygii 5 parts, Caulis Spatholobi 13 parts, Ramulus Uncariae Cum Uncis 14 parts, Rhizoma Chuanxiong 5 parts, Folium Crossostephii Chinensis 12 parts, Herba Saussureae Involueratae 3 parts, Folium Eucommiae 1 part, Pericarpium Citri Reticulatae 10 parts, Radix Notoginseng 9 parts, Rhizoma Polygoni Cuspidati 13 parts, Pheretima 7 parts, Herba Portulacae 11 parts, Folium Ginkgo 3 parts, 1 part of Poria, Radix Puerariae 10 parts, Semen Cassiae 4 parts, Fructus Crataegi 11 parts, 4 parts of Rhizoma Gastrodiae。
7. the pharmaceutical composition of vessel softening according to claim 1, it is characterized in that: make described pharmaceutical composition raw material composition and parts by weight be: 15 parts of crataegus pin natifida var. Major leaf, Scorpio 12 parts, Radix Angelicae Sinensis 5 parts, Squama Manis 9 parts, Radix Achyranthis Bidentatae 15 parts, Radix Salviae Miltiorrhizae 9 parts, 7 parts of Flos Carthami, the Rhizoma Atractylodis Macrocephalae 19 parts, Fructus Atriplicis Sibiricae 13 parts, Herba Artemisiae Scopariae 10 parts, Cortex Mori 4 parts, Rhizoma Et Radix Notopterygii 4 parts, Caulis Spatholobi 11 parts, Ramulus Uncariae Cum Uncis 11 parts, Rhizoma Chuanxiong 5 parts, Folium Crossostephii Chinensis 10 parts, Herba Saussureae Involueratae 5 parts, Folium Eucommiae 3 parts, Pericarpium Citri Reticulatae 8 parts, Radix Notoginseng 8 parts, Rhizoma Polygoni Cuspidati 14 parts, Pheretima 9 parts, Herba Portulacae 12 parts, Folium Ginkgo 5 parts, 3 parts of Poria, Radix Puerariae 8 parts, Semen Cassiae 6 parts, Fructus Crataegi 9 parts, 5 parts of Rhizoma Gastrodiae。
8. the pharmaceutical composition of vessel softening according to claim 1, it is characterized in that: make described pharmaceutical composition raw material composition and parts by weight be: 19 parts of crataegus pin natifida var. Major leaf, Scorpio 14 parts, Radix Angelicae Sinensis 6 parts, Squama Manis 7 parts, Radix Achyranthis Bidentatae 14 parts, Radix Salviae Miltiorrhizae 9 parts, 6 parts of Flos Carthami, the Rhizoma Atractylodis Macrocephalae 17 parts, Fructus Atriplicis Sibiricae 13 parts, Herba Artemisiae Scopariae 10 parts, Cortex Mori 4 parts, Rhizoma Et Radix Notopterygii 4 parts, Caulis Spatholobi 11 parts, Ramulus Uncariae Cum Uncis 11 parts, Rhizoma Chuanxiong 5 parts, Folium Crossostephii Chinensis 10 parts, Herba Saussureae Involueratae 5 parts, Folium Eucommiae 3 parts, Pericarpium Citri Reticulatae 8 parts, Radix Notoginseng 8 parts, Rhizoma Polygoni Cuspidati 14 parts, Pheretima 4 parts, Herba Portulacae 9 parts, Folium Ginkgo 5 parts, 3 parts of Poria, Radix Puerariae 8 parts, Semen Cassiae 3 parts, Fructus Crataegi 8 parts, 5 parts of Rhizoma Gastrodiae。
9. the pharmaceutical composition according to the arbitrary described vessel softening of claim 3-8, it is characterised in that: described Chinese medicine composition is prepared in following manner:
(1) each medical material of components by weight percent in the arbitrary described pharmaceutical composition of claim 3-8 is taken, add in the ethanol of 5-10 times amount and soak 1-2 hour, heating extraction 2 times, each 1-2 hour, removes supernatant, united extraction liquid, 100-120 order filters, the ultrafiltration post ultrafiltration that molecular weight is 5000-10000 then through damming, the extractum of 1.36 when ultrafiltrate concentrating under reduced pressure relative density is 80 DEG C, heating is concentrated into paste, stand for standby use;
(2) being put in 10 times amount water by the medicinal residues that ethanol extraction is crossed, be then placed in extraction pot heated and boiled 1 hour, filter, filtrate is standby;Filtering residue adds water, second time heating, boils 45 minutes, filters, and filtrate is standby;
(3) 2 filtrates in step (2) being combined, by filtered through gauze, add 50-60% ethanol in residue, 60 DEG C-70 DEG C are continued lixiviate 2h, every 10min and stir once, and filtered through gauze merges lixiviating solution, is condensed into pasty state;
(4) the pastel decompression recycling ethanol that step (1) paste that obtains of concentration and step (3) obtained to be concentrated into liquor strength be 0.6-0.7g crude drug/mL, after sucking filtration, the relative density of filtrate is about 1.0-1.1 when 20 DEG C;It is centrifuged under the rotating speed of 3000r/min;At 60 DEG C of-80 DEG C of spray drying, obtain dry extract;
(5) dry extract that step (4) prepares is pulverized, add suitable amount of sucrose, dextrin mixing, with ethanol for wetting agent, granulate, dry, granulate, granule can be prepared;Or the dry extract that step (4) prepares be dry, pulverize, make powder;Or dry extract step (4) prepared is pulverized, add appropriate micropowder silica gel, α-galactose mixing, with ethanol for wetting agent, granulate, dry, granulate, encapsulated, prepare capsule;Or dry extract step (4) prepared is pulverized, add suitable amount of sucrose, dextrin mixing, with ethanol for wetting agent, granulate, dry, granulate, tabletting, prepare tablet;Or to above-mentioned steps (4) obtain centrifugal after concentrated solution in add suitable amount of sucrose, essence mixing, sterilizing, fill, prepare medicinal liquid agent。
10. the application in vessel softening medicine of the pharmaceutical composition of the vessel softening as described in as arbitrary in claim 1-9。
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201610125271.9A CN105687788A (en) | 2016-03-04 | 2016-03-04 | Pharmaceutical composition capable of softening blood vessels and application thereof |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201610125271.9A CN105687788A (en) | 2016-03-04 | 2016-03-04 | Pharmaceutical composition capable of softening blood vessels and application thereof |
Publications (1)
Publication Number | Publication Date |
---|---|
CN105687788A true CN105687788A (en) | 2016-06-22 |
Family
ID=56220812
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201610125271.9A Pending CN105687788A (en) | 2016-03-04 | 2016-03-04 | Pharmaceutical composition capable of softening blood vessels and application thereof |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN105687788A (en) |
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN106038971A (en) * | 2016-07-06 | 2016-10-26 | 侯小芳 | Traditional Chinese medicine for treating hypertension and preparation method of traditional Chinese medicine for treating hypertension |
CN107616261A (en) * | 2017-10-27 | 2018-01-23 | 羊楼洞茶业股份有限公司 | One kind thorn certain kind of berries green brick tea and preparation method thereof |
CN114224979A (en) * | 2021-12-23 | 2022-03-25 | 庞德东 | Medicine for softening blood vessel and preparation method thereof |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN104304602A (en) * | 2014-11-24 | 2015-01-28 | 青岛恒波仪器有限公司 | Pagoda tree fruit tea capable of softening blood vessels and preparation method thereof |
CN104857121A (en) * | 2015-05-05 | 2015-08-26 | 青岛市市立医院 | Drug combination for curing hyperlipidemia and application thereof |
-
2016
- 2016-03-04 CN CN201610125271.9A patent/CN105687788A/en active Pending
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN104304602A (en) * | 2014-11-24 | 2015-01-28 | 青岛恒波仪器有限公司 | Pagoda tree fruit tea capable of softening blood vessels and preparation method thereof |
CN104857121A (en) * | 2015-05-05 | 2015-08-26 | 青岛市市立医院 | Drug combination for curing hyperlipidemia and application thereof |
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN106038971A (en) * | 2016-07-06 | 2016-10-26 | 侯小芳 | Traditional Chinese medicine for treating hypertension and preparation method of traditional Chinese medicine for treating hypertension |
CN107616261A (en) * | 2017-10-27 | 2018-01-23 | 羊楼洞茶业股份有限公司 | One kind thorn certain kind of berries green brick tea and preparation method thereof |
CN114224979A (en) * | 2021-12-23 | 2022-03-25 | 庞德东 | Medicine for softening blood vessel and preparation method thereof |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN103520572B (en) | A kind of Chinese medicine composition being used for the treatment of atopic dermatitis and preparation method thereof | |
CN103690783B (en) | Chinese medicine preparation being used for the treatment of diabetes and preparation method thereof | |
CN104208302A (en) | Fructus rosae laevigatae healthy oral solution for reducing blood fat and preparation method thereof | |
CN104666579A (en) | Traditional Chinese medicine composition for treating gonarthromeningitis and preparation method of traditional Chinese medicine composition | |
CN104758806A (en) | Decocted extract for treating coronary heart disease and preparation method thereof | |
CN103749824B (en) | A kind of Herb Gynostemmae Pentaphylli blood sugar lowering blood pressure depressing health tea and preparation method thereof | |
CN103749821B (en) | A kind of gynostemma pentaphylla health-care tea improving immunity and preparation method thereof | |
CN103211930A (en) | Traditional Chinese preparation for reducing blood fat and blood pressure | |
CN105664099A (en) | Traditional Chinese medicine composition for warming and invigorating kidney yang and preparation method thereof | |
CN101804110B (en) | Traditional Chinese medicine preparation for thrombosis and blood lipid | |
CN105687788A (en) | Pharmaceutical composition capable of softening blood vessels and application thereof | |
CN104206595A (en) | Blood lipid and blood glucose reducing Chinese wolfberry root-bark health care tea and preparation method thereof | |
CN103919910A (en) | Medicine for treating coronary heart disease | |
CN105012873A (en) | Health-care blood-fat-lowering evening primrose oral liquid and preparation method thereof | |
CN105394282A (en) | Radix puerariae health tea capable of reducing blood pressure, blood sugar and blood lipid | |
CN103860773A (en) | Traditional Chinese medicine composition for treating myocardial ischemia and preparation method thereof | |
CN104857121A (en) | Drug combination for curing hyperlipidemia and application thereof | |
CN104491718B (en) | Medicine for treating liver-depression and phlegm-stasis type mammary gland hyperplasia and preparation method | |
CN104524479B (en) | A kind of Chinese medicine composition for treating premenstrual syndrome and preparation method thereof | |
CN105381220A (en) | Dodder healthy tea having functions of improving eyesight and reducing lipid | |
CN104800600A (en) | Medicine for treating hypertension | |
CN103860948A (en) | Traditional Chinese medicine for treating acute mastitis caused by qi stagnation and heat congestion and preparation method thereof | |
CN103341108B (en) | Pharmaceutical composite for treating stress urinary incontinence after prostatectomy | |
CN103520644B (en) | Traditional Chinese medicine composition used for treating phlegm stagnation type hyperlipidaemia and preparation method of composition | |
CN105125886A (en) | Traditional Chinese medicine composition for preventing and treating diabetes and complications of diabetes |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
RJ01 | Rejection of invention patent application after publication | ||
RJ01 | Rejection of invention patent application after publication |
Application publication date: 20160622 |